196 results on '"Baggett, Henry C."'
Search Results
152. Mumps outbreak in an unimmunized population - Luanshya District, Copperbelt Province, Zambia, 2015.
- Author
-
Kateule, Ernest, Kumar, Ramya, Mulenga, Modest, Daka, Victor, Banda, Kelvin, Anderson, Raydel, McNall, Rebecca, McGrew, Marcia, Baggett, Henry C., and Kasongo, Webster
- Subjects
- *
MUMPS , *IMMUNOGLOBULIN M , *VIRUS diseases , *SALIVARY glands , *IMMUNIZATION , *VACCINATION - Abstract
Introduction: Mumps is a vaccine-preventable viral disease that may cause deafness, orchitis, encephalitis or death. However, mumps vaccine is not included in Zambia's Expanded Program for Immunization. In January 2015, Integrated Disease Surveillance and Response data revealed an increase in reported mumps cases in Luanshya District. We investigated to confirm the etiology and generate epidemiological data on mumps in Zambia. Methods: We conducted active case finding, examined possible case-patients, and administered a standard questionnaire. A suspected mumps case was defined as acute onset of salivary gland swelling in a Luanshya resident during January - June 2015. Eight case-patients provided serum samples to test for mumps-specific immunoglobulin IgM, and buccal swabs to test for mumps viral RNA by RT-PCR, and genotyping of mumps virus at the Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Results: From January - June 2015, a total of 283 mumps cases were reported in Luanshya, peaking in April (71 cases) and clustering (81%) in two townships. Of 72 suspected case-patients interviewed, 81% were aged < 15 years (29%, 1 - 4 years) and 61% were female. Common clinical characteristics were buccal tenderness (29%) and fever > 37.5ºC (29%). Mumps virus genotype D was confirmed in five case-patients who tested positive by RT-PCR; six case-patients were sero-positive for anti-mumps IgM antibodies (total seven lab-confirmed cases). Conclusion: Our findings represent the first reported epidemiologic description of mumps in Zambia. While the epidemiology is consistent with prior descriptions of mumps in unimmunized populations and no serious complications arose, this report provides data to inform policy discussions regarding mumps vaccination in Zambia. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
153. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.
- Author
-
Ting Shi, McAllister, David A., O'Brien, Katherine L., Simoes, Eric A. F., Madhi, Shabir A., Gessner, Bradford D., Polack, Fernando P., Balsells, Evelyn, Acacio, Sozinho, Aguayo, Claudia, Alassani, Issifou, Ali, Asad, Antonio, Martin, Awasthi, Shally, Awori, Juliet O., Azziz-Baumgartner, Eduardo, Baggett, Henry C., Baillie, Vicky L., Balmaseda, Angel, and Barahona, Alfredo
- Subjects
- *
RESPIRATORY infections , *RESPIRATORY syncytial virus , *JUVENILE diseases , *CHILD mortality , *HOSPITAL admission & discharge , *HOSPITAL care , *WORLD health , *SYSTEMATIC reviews , *DISEASE incidence , *STATISTICAL models , *HOSPITAL mortality ,DEVELOPING countries - Abstract
Background: We have previously estimated that respiratory syncytial virus (RSV) was associated with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in 55 000 to 199 000 deaths in children younger than 5 years in 2005. In the past 5 years, major research activity on RSV has yielded substantial new data from developing countries. With a considerably expanded dataset from a large international collaboration, we aimed to estimate the global incidence, hospital admission rate, and mortality from RSV-ALRI episodes in young children in 2015.Methods: We estimated the incidence and hospital admission rate of RSV-associated ALRI (RSV-ALRI) in children younger than 5 years stratified by age and World Bank income regions from a systematic review of studies published between Jan 1, 1995, and Dec 31, 2016, and unpublished data from 76 high quality population-based studies. We estimated the RSV-ALRI incidence for 132 developing countries using a risk factor-based model and 2015 population estimates. We estimated the in-hospital RSV-ALRI mortality by combining in-hospital case fatality ratios with hospital admission estimates from hospital-based (published and unpublished) studies. We also estimated overall RSV-ALRI mortality by identifying studies reporting monthly data for ALRI mortality in the community and RSV activity.Findings: We estimated that globally in 2015, 33·1 million (uncertainty range [UR] 21·6-50·3) episodes of RSV-ALRI, resulted in about 3·2 million (2·7-3·8) hospital admissions, and 59 600 (48 000-74 500) in-hospital deaths in children younger than 5 years. In children younger than 6 months, 1·4 million (UR 1·2-1·7) hospital admissions, and 27 300 (UR 20 700-36 200) in-hospital deaths were due to RSV-ALRI. We also estimated that the overall RSV-ALRI mortality could be as high as 118 200 (UR 94 600-149 400). Incidence and mortality varied substantially from year to year in any given population.Interpretation: Globally, RSV is a common cause of childhood ALRI and a major cause of hospital admissions in young children, resulting in a substantial burden on health-care services. About 45% of hospital admissions and in-hospital deaths due to RSV-ALRI occur in children younger than 6 months. An effective maternal RSV vaccine or monoclonal antibody could have a substantial effect on disease burden in this age group.Funding: The Bill & Melinda Gates Foundation. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
154. The Pneumonia Etiology Research for Child Health Project: A 21st Century Childhood Pneumonia Etiology Study.
- Author
-
Levine, Orin S., O'Brien, Katherine L., Deloria-Knoll, Maria, Murdoch, David R., Feikin, Daniel R., DeLuca, Andrea N., Driscoll, Amanda J., Baggett, Henry C., Brooks, W. Abdullah, Howie, Stephen R. C., Kotloff, Karen L., Madhi, Shabir A., Maloney, Susan A., Sow, Samba, Thea, Donald M., and Scott, J. Anthony
- Subjects
- *
PNEUMONIA in children , *ETIOLOGY of diseases , *INFLUENZA vaccines , *EPIDEMIOLOGY , *PATHOGENIC microorganisms , *HAEMOPHILUS influenzae ,DEVELOPING countries - Abstract
The Pneumonia Etiology Research for Child Health (PERCH) project is a 7-country, standardized, comprehensive evaluation of the etiologic agents causing severe pneumonia in children from developing countries. During previous etiology studies, between one-quarter and one-third of patients failed to yield an obvious etiology; PERCH will employ and evaluate previously unavailable innovative, more sensitive diagnostic techniques. Innovative and rigorous epidemiologic and analytic methods will be used to establish the causal association between presence of potential pathogens and pneumonia. By strategic selection of study sites that are broadly representative of regions with the greatest burden of childhood pneumonia, PERCH aims to provide data that reflect the epidemiologic situation in developing countries in 2015, using pneumococcal and Haemophilus influenzae type b vaccines. PERCH will also address differences in host, environmental, and/or geographic factors that might determine pneumonia etiology and, by preserving specimens, will generate a resource for future research and pathogen discovery. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
155. Indirect Effect of Conjugate Vaccine on Adult Carriage of Streptococcus pneumoniae: An Explanation of Trends in Invasive Pneumococcal Disease.
- Author
-
Hammitt, Laura L., Bruden, Dana L., Butler, Jay C., Baggett, Henry C., Hurlburt, Debby A., Reasonover, Alisa, and Hennessy, Thomas W.
- Subjects
- *
VACCINATION , *STREPTOCOCCUS pneumoniae , *IMMUNIZATION of children , *PREVENTIVE medicine , *ANTIBACTERIAL agents - Abstract
Background. Use of heptavalent protein-polysaccharide pneumococcal conjugate vaccine (PCV7) has been associated with decreases in PCV7-type invasive pneumococcal disease and nasopharyngeal (NP) carriage in children. Vaccine use has also indirectly decreased the rate of invasive disease in adults, presumably through decreased transmission of pneumococci from vaccinated children to adults. Methods. We conducted NP carriage surveys in 8 villages in Alaska in 1998-2004. Streptococcus pneumoniae isolates were characterized by serotype and antimicrobial susceptibility. We analyzed trends in serotype distribution, antibiotic resistance, and factors associated with adult carriage of PCV7-serotype pneumococci before and after the introduction of PCV7 in 2001. Results. We collected 15,598 NP swabs; overall, 52% of adults living in the villages surveyed participated in the colonization study. The proportion of adult carriers with PCV7-type pneumococcal carriage decreased from 28% of carriers in 1998-2000 to 4.5% of carriers in 2004 (P < .0001). Among adults, the proportion of colonizing isolates that were resistant to penicillin decreased from 13% in 1998-2000 to 6% in 2004 (P =.05), whereas the percentage of isolates with intermediate susceptibility to penicillin increased from 12% in 1998-2000 to 19% in 2004 (P < .01). Adults were more likely to carry PCV7-type pneumococci if they lived with a child <5 years old or if they lived with a child who had not been age-appropriately vaccinated with PCV7. Conclusions. Pediatric vaccination with PCV7 has resulted in decreased PCV7-type pneumococcal carriage among adults and helps to explain recent decreases in the rate of PCV7-type invasive pneumococcal disease among adults. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
156. Epidemiology of the Rhinovirus (RV) in African and Southeast Asian Children: A Case-Control Pneumonia Etiology Study.
- Author
-
Baillie, Vicky L., Moore, David P., Mathunjwa, Azwifarwi, Baggett, Henry C., Brooks, Abdullah, Feikin, Daniel R., Hammitt, Laura L., Howie, Stephen R. C., Knoll, Maria Deloria, Kotloff, Karen L., Levine, Orin S., O'Brien, Katherine L., Scott, Anthony G., Thea, Donald M., Antonio, Martin, Awori, Juliet O., Driscoll, Amanda J., Fancourt, Nicholas S. S., Higdon, Melissa M., and Karron, Ruth A.
- Subjects
- *
ETIOLOGY of pneumonia , *ASIANS , *RHINOVIRUSES , *HOSPITAL care of children , *RESPIRATORY infections , *EPIDEMIOLOGY , *PNEUMONIA - Abstract
Rhinovirus (RV) is commonly detected in asymptomatic children; hence, its pathogenicity during childhood pneumonia remains controversial. We evaluated RV epidemiology in HIV-uninfected children hospitalized with clinical pneumonia and among community controls. PERCH was a case-control study that enrolled children (1–59 months) hospitalized with severe and very severe pneumonia per World Health Organization clinical criteria and age-frequency-matched community controls in seven countries. Nasopharyngeal/oropharyngeal swabs were collected for all participants, combined, and tested for RV and 18 other respiratory viruses using the Fast Track multiplex real-time PCR assay. RV detection was more common among cases (24%) than controls (21%) (aOR = 1.5, 95%CI:1.3–1.6). This association was driven by the children aged 12–59 months, where 28% of cases vs. 18% of controls were RV-positive (aOR = 2.1, 95%CI:1.8–2.5). Wheezing was 1.8-fold (aOR 95%CI:1.4–2.2) more prevalent among pneumonia cases who were RV-positive vs. RV-negative. Of the RV-positive cases, 13% had a higher probability (>75%) that RV was the cause of their pneumonia based on the PERCH integrated etiology analysis; 99% of these cases occurred in children over 12 months in Bangladesh. RV was commonly identified in both cases and controls and was significantly associated with severe pneumonia status among children over 12 months of age, particularly those in Bangladesh. RV-positive pneumonia was associated with wheezing. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
157. Pneumococcal pneumonia prevalence among adults with severe acute respiratory illness in Thailand - comparison of Bayesian latent class modeling and conventional analysis.
- Author
-
Lu, Ying, Joseph, Lawrence, Bélisle, Patrick, Sawatwong, Pongpun, Jatapai, Anchalee, Whistler, Toni, Thamthitiwat, Somsak, Paveenkittiporn, Wantana, Khemla, Supphacoke, Van Beneden, Chris A., Baggett, Henry C., and Gregory, Christopher J.
- Subjects
- *
PNEUMOCOCCAL pneumonia , *COMMUNITY-acquired pneumonia , *ACUTE diseases , *ETIOLOGY of diseases , *POLYMERASE chain reaction , *DISEASE prevalence , *DIAGNOSIS methods - Abstract
Background: Determining the etiology of pneumonia is essential to guide public health interventions. Diagnostic test results, including from polymerase chain reaction (PCR) assays of upper respiratory tract specimens, have been used to estimate prevalence of pneumococcal pneumonia. However limitations in test sensitivity and specificity and the specimen types available make establishing a definitive diagnosis challenging. Prevalence estimates for pneumococcal pneumonia could be biased in the absence of a true gold standard reference test for detecting Streptococcus pneumoniae.Methods: We conducted a case control study to identify etiologies of community acquired pneumonia (CAP) from April 2014 through August 2015 in Thailand. We estimated the prevalence of pneumococcal pneumonia among adults hospitalized for CAP using Bayesian latent class models (BLCMs) incorporating results of real-time polymerase chain reaction (qPCR) testing of upper respiratory tract specimens and a urine antigen test (UAT) from cases and controls. We compared the prevalence estimate to conventional analyses using only UAT as a reference test.Results: The estimated prevalence of pneumococcal pneumonia was 8% (95% CI: 5-11%) by conventional analyses. By BLCM, we estimated the prevalence to be 10% (95% CrI: 7-16%) using binary qPCR and UAT results, and 11% (95% CrI: 7-17%) using binary UAT results and qPCR cycle threshold (Ct) values.Conclusions: BLCM suggests a > 25% higher prevalence of pneumococcal pneumonia than estimated by a conventional approach assuming UAT as a gold standard reference test. Higher quantities of pneumococcal DNA in the upper respiratory tract were associated with pneumococcal pneumonia in adults but the addition of a second specific pneumococcal test was required to accurately estimate disease status and prevalence. By incorporating the inherent uncertainty of diagnostic tests, BLCM can obtain more reliable estimates of disease status and improve understanding of underlying etiology. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
158. Population-based bloodstream infection surveillance in rural Thailand, 2007-2014.
- Author
-
Rhodes, Julia, Jorakate, Possawat, Makprasert, Sirirat, Sangwichian, Ornuma, Kaewpan, Anek, Akarachotpong, Thantapat, Srisaengchai, Prasong, Thamthitiwat, Somsak, Khemla, Supphachoke, Yuenprakhon, Somkid, Paveenkittiporn, Wantana, Kerdsin, Anusak, Whistler, Toni, Baggett, Henry C., and Gregory, Christopher J.
- Subjects
- *
BURKHOLDERIA pseudomallei , *STREPTOCOCCUS pyogenes , *STREPTOCOCCUS agalactiae , *ESCHERICHIA coli , *MULTIDRUG resistance , *MELIOIDOSIS - Abstract
Background: Bloodstream infection (BSI) surveillance is essential to characterize the public health threat of bacteremia. We summarize BSI epidemiology in rural Thailand over an eight year period.Methods: Population-based surveillance captured clinically indicated blood cultures and associated antimicrobial susceptibility results performed in all 20 hospitals in Nakhon Phanom (NP) and Sa Kaeo (SK) provinces. BSIs were classified as community-onset (CO) when positive cultures were obtained ≤2 days after hospital admission and hospital-onset (HO) thereafter. Hospitalization denominator data were available for incidence estimates for 2009-2014.Results: From 2007 to 2014 a total of 11,166 BSIs were identified from 134,441 blood cultures. Annual CO BSI incidence ranged between 89.2 and 123.5 cases per 100,000 persons in SK and NP until 2011. Afterwards, CO incidence remained stable in SK and increased in NP, reaching 155.7 in 2013. Increases in CO BSI incidence over time were limited to persons aged ≥50 years. Ten pathogens, in rank order, accounted for > 65% of CO BSIs in both provinces, all age-groups, and all years: Escherichia coli, Klebsiella pneumoniae, Burkholderia pseudomallei, Staphylococcus aureus, Salmonella non-typhi spp., Streptococcus pneumoniae, Acinetobacter spp., Streptococcus agalactiae, Streptococcus pyogenes, Pseudomonas aeruginosa. HO BSI incidence increased in NP from 0.58 cases per 1000 hospitalizations in 2009 to 0.91 in 2014, but were higher (ranging from 1.9 to 2.3) in SK throughout the study period. Extended-spectrum beta-lactamase production among E. coli isolates and multi-drug resistance among Acinetobacter spp. isolates was common (> 25% of isolates), especially among HO cases (> 50% of isolates), and became more common over time, while methicillin-resistance among S. aureus isolates (10%) showed no clear trend. Carbapenem-resistant Enterobacteriaceae were documented in 2011-2014.Conclusions: Population-based surveillance documented CO BSI incidence estimates higher than previously reported from Thailand and the region, with temporal increases seen in older populations. The most commonly observed pathogens including resistance profiles were similar to leading pathogens and resistance profiles worldwide, thus; prevention strategies with demonstrated success elsewhere may prove effective in Thailand. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
159. Hospitalizations for Acute Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Thailand, 2008–2011.
- Author
-
Naorat, Sathapana, Chittaganpitch, Malinee, Thamthitiwat, Somsak, Henchaichon, Sununta, Sawatwong, Pongpun, Srisaengchai, Prasong, Lu, Ying, Chuananon, Somchai, Amornintapichet, Tussanee, Chantra, Somrak, Erdman, Dean D., Maloney, Susan A., Akarasewi, Passakorn, and Baggett, Henry C.
- Subjects
- *
RESPIRATORY infections , *RESPIRATORY syncytial virus , *POLYMERASE chain reaction , *HOSPITAL care - Abstract
Background. Few population-based estimates of the incidence of respiratory syncytial virus (RSV) infection in low- or middle-income countries are available. We describe the incidence and epidemiology of hospitalizations for RSV-associated acute lower respiratory tract infection (ALRI) detected by active population-based surveillance in 2 rural Thailand provinces during 2008–2011.Methods. Patients hospitalized with ALRI were systematically sampled. Consenting patients provided nasopharyngeal swab specimens for RSV testing by real-time reverse-transcription polymerase chain reaction.Results. Of 13 982 enrolled patients hospitalized with ALRI, 1137 (8.1%) were RSV positive. After adjustment for sampling and nonenrollment, the incidence of RSV-associated ALRI hospitalization was 85 cases per 100 000 persons/year. The highest rates occurred among children aged <5 years (981 cases per 100 000 persons/year) and <1 year (1543 cases per 100 000 persons/year). Rates were low among older children and young adults but high among persons aged >65 years (130 cases per 100 000 persons/year). Eight (0.7%) RSV-infected study patients died during hospitalization. Annual RSV hospitalizations peaked during July-October with almost no documented RSV hospitalizations during January–June.Conclusions. Our findings demonstrate the substantial contribution of RSV to global ALRI burden, especially in children aged <5 years and the elderly, and underscore the urgent need for effective prevention measures. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
160. Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for management.
- Author
-
Gallagher KE, Awori JO, Knoll MD, Rhodes J, Higdon MM, Hammitt LL, Prosperi C, Baggett HC, Brooks WA, Fancourt N, Feikin DR, Howie SRC, Kotloff KL, Tapia MD, Levine OS, Madhi SA, Murdoch DR, O'Brien KL, Thea DM, Baillie VL, Ebruke BE, Kamau A, Moore DP, Mwananyanda L, Olutunde EO, Seidenberg P, Sow SO, Thamthitiwat S, and Scott JAG
- Subjects
- Infant, Child, Humans, Child, Preschool, Hospitalization, Hypoxia etiology, Pneumonia epidemiology, Malnutrition complications, HIV Infections complications
- Abstract
Introduction: In 2012, the World Health Organization revised treatment guidelines for childhood pneumonia with lower chest wall indrawing (LCWI) but no 'danger signs', to recommend home-based treatment. We analysed data from children hospitalized with LCWI pneumonia in the Pneumonia Etiology Research for Child Health (PERCH) study to identify sub-groups with high odds of mortality, who might continue to benefit from hospital management but may not be admitted by staff implementing the 2012 guidelines. We compare the proportion of deaths identified using the criteria in the 2012 guidelines, and the proportion of deaths identified using an alternative set of criteria from our model., Methods: PERCH enrolled a cohort of 2189 HIV-negative children aged 2-59 months who were admitted to hospital with LCWI pneumonia (without obvious cyanosis, inability to feed, vomiting, convulsions, lethargy or head nodding) between 2011-2014 in Kenya, Zambia, South Africa, Mali, The Gambia, Bangladesh, and Thailand. We analysed risk factors for mortality among these cases using predictive logistic regression. Malnutrition was defined as mid-upper-arm circumference <125mm or weight-for-age z-score <-2., Results: Among 2189 cases, 76 (3·6%) died. Mortality was associated with oxygen saturation <92% (aOR 3·33, 1·99-5·99), HIV negative but exposed status (4·59, 1·81-11·7), moderate or severe malnutrition (6·85, 3·22-14·6) and younger age (infants compared to children 12-59 months old, OR 2·03, 95%CI 1·05-3·93). At least one of three risk factors: hypoxaemia, HIV exposure, or malnutrition identified 807 children in this population, 40% of LCWI pneumonia cases and identified 86% of the children who died in hospital (65/76). Risk factors identified using the 2012 WHO treatment guidelines identified 66% of the children who died in hospital (n = 50/76)., Conclusions: Although it focuses on treatment failure in hospital, this study supports the proposal for better risk stratification of children with LCWI pneumonia. Those who have hypoxaemia, any malnutrition or those who were born to HIV positive mothers, experience poorer outcomes than other children with LCWI pneumonia. Consistent identification of these risk factors should be prioritised and children with at least one of these risk factors should not be managed in the community., Competing Interests: The authors have declared that no competing interests exist., (Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.)
- Published
- 2024
- Full Text
- View/download PDF
161. Qualitative evaluation of enabling factors and barriers to the success and sustainability of national public health institutes in Cambodia, Colombia, Liberia, Mozambique, Nigeria, Rwanda and Zambia.
- Author
-
Woldetsadik MA, Bratton S, Fitzpatrick K, Ravat F, Del Castillo L, McIntosh KJ, Jarvis D, Carnevale CR, Cassell CH, Chhea C, Prieto Alvarado F, MaCauley J, Jani I, Ilori E, Nsanzimana S, Mukonka VM, and Baggett HC
- Subjects
- Cambodia, Causality, Colombia, Humans, Liberia, Mozambique, Nigeria, Rwanda, Zambia, Public Health
- Abstract
Objectives: The success of National Public Health Institutes (NPHIs) in low-income and middle-income countries (LMICs) is critical to countries' ability to deliver public health services to their populations and effectively respond to public health emergencies. However, empirical data are limited on factors that promote or are barriers to the sustainability of NPHIs. This evaluation explored stakeholders' perceptions about enabling factors and barriers to the success and sustainability of NPHIs in seven countries where the U.S. Centers for Disease Control and Prevention (CDC) has supported NPHI development and strengthening., Design: Qualitative study., Setting: Cambodia, Colombia, Liberia, Mozambique, Nigeria, Rwanda and Zambia., Participants: NPHI staff, non-NPHI government staff, and non-governmental and international organisation staff., Methods: We conducted semistructured, in-person interviews at a location chosen by the participants in the seven countries. We analysed data using a directed content analysis approach., Results: We interviewed 43 NPHI staff, 29 non-NPHI government staff and 24 staff from non-governmental and international organisations. Participants identified five enabling factors critical to the success and sustainability of NPHIs: (1) strong leadership, (2) financial autonomy, (3) political commitment and country ownership, (4) strengthening capacity of NPHI staff and (5) forming strategic partnerships. Three themes emerged related to major barriers or threats to the sustainability of NPHIs: (1) reliance on partner funding to maintain key activities, (2) changes in NPHI leadership and (3) staff attrition and turnover., Conclusions: Our findings contribute to the scant literature on sustainability of NPHIs in LMICs by identifying essential components of sustainability and types of support needed from various stakeholders. Integrating these components into each step of NPHI development and ensuring sufficient support will be critical to strengthening public health systems and safeguarding their continuity. Our findings offer potential approaches for country leadership to direct efforts to strengthen and sustain NPHIs., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
162. Strengthening the global one health workforce: Veterinarians in CDC-supported field epidemiology training programs.
- Author
-
Seffren V, Lowther S, Guerra M, Kinzer MH, Turcios-Ruiz R, Henderson A, Shadomy S, Baggett HC, Harris JR, Njoh E, and Salyer SJ
- Abstract
Background: Effective prevention, detection, and response to disease threats at the human-animal-environment interface rely on a multisectoral, One Health workforce. Since 2009, the U.S. Centers for Disease Control and Prevention (CDC) has supported Field Epidemiology Training Programs (FETPs) to train veterinarians and veterinary paraprofessionals (VPPs) alongside their human health counterparts in the principles of epidemiology, disease surveillance, and outbreak investigations. We aim to describe and evaluate characteristics of CDC-supported FETPs enrolling veterinarians/VPPs to understand these programs contribution to the strengthening of the global One Health workforce., Methods: We surveyed staff from CDC-supported FETPs that enroll veterinarians and VPPs regarding cohort demographics, graduate retention, and veterinary and One Health relevant curriculum inclusion. Descriptive data was analyzed using R Version 3.5.1., Results: Forty-seven FETPs reported veterinarian/VPP trainees, 68% responded to our questionnaire, and 64% reported veterinary/VPP graduates in 2017. The veterinary/VPP graduates in 2017 made up 12% of cohorts. Programs reported 74% of graduated veterinarians/VPPs retained employment within national ministries of agriculture. Common veterinary and One Health curriculum topics were specimen collection and submission (93%), zoonotic disease (90%) and biosafety practices (83%); least covered included animal/livestock production and health promotion (23%) and transboundary animal diseases (27%). Less than half (41%) of programs reported the curriculum being sufficient for veterinarians/VPPs to perform animal health specific job functions, despite most programs being linked to the ministry of agriculture (75%) and providing veterinary-specific mentorship (63%)., Conclusions: Our results indicate that FETPs provide valuable training opportunities for animal health sector professionals, strengthening the epidemiology capacity within the ministries retaining them. While veterinary/VPP trainees could benefit from the inclusion of animal-specific curricula needed to fulfill their job functions, at present, FETPs continue to serve as multisectoral, competency-based, in-service training important in strengthening the global One Health workforce by jointly training the animal and human health sectors., Competing Interests: The authors declare that they have no competing interests.
- Published
- 2022
- Full Text
- View/download PDF
163. Field epidemiology training programs contribute to COVID-19 preparedness and response globally.
- Author
-
Hu AE, Fontaine R, Turcios-Ruiz R, Abedi AA, Williams S, Hilmers A, Njoh E, Bell E, Reddy C, Ijaz K, and Baggett HC
- Subjects
- Cross-Sectional Studies, Disease Outbreaks, Humans, Public Health, SARS-CoV-2, COVID-19
- Abstract
Background: Field epidemiology training programs (FETPs) have trained field epidemiologists who strengthen global capacities for surveillance and response to public health threats. We describe how FETP residents and graduates have contributed to COVID-19 preparedness and response globally., Methods: We conducted a cross-sectional survey of FETPs between March 13 and April 15, 2020 to understand how FETP residents or graduates were contributing to COVID-19 response activities. The survey tool was structured around the eight Pillars of the World Health Organization's (WHO) Strategic Preparedness and Response Plan for COVID-19. We used descriptive statistics to summarize quantitative results and content analysis for qualitative data., Results: Among 88 invited programs, 65 (74%) responded and indicated that FETP residents and graduates have engaged in the COVID-19 response across all six WHO regions. Response efforts focused on country-level coordination (98%), surveillance, rapid response teams, case investigations (97%), activities at points of entry (92%), and risk communication and community engagement (82%). Descriptions of FETP contributions to COVID-19 preparedness and response are categorized into seven main themes: conducting epidemiological activities, managing logistics and coordination, leading risk communication efforts, providing guidance, supporting surveillance activities, training and developing the workforce, and holding leadership positions., Conclusions: Our findings demonstrate the value of FETPs in responding to public health threats like COVID-19. This program provides critical assistance to countries' COVID-19 response efforts but also enhances epidemiologic workforce capacity, public health emergency infrastructure and helps ensure global health security as prescribed in the WHO's International Health Regulations., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
164. Stakeholders' assessment of US Centers for Disease Control and Prevention's contributions to the development of National Public Health Institutes in seven countries.
- Author
-
Woldetsadik MA, Fitzpatrick K, Del Castillo L, Miller B, Jarvis D, Carnevale C, Ravat F, Cassell CH, Williams A, Young SK, Clemente J, Baggett HC, and Bratton S
- Subjects
- Capacity Building, Centers for Disease Control and Prevention, U.S., Global Health, Humans, United States, International Cooperation, Public Health
- Abstract
National Public Health Institutes (NPHIs) can strengthen countries' public health capacities to prevent, detect, and respond to public health emergencies. This qualitative evaluation assessed the role of the US Centers for Disease Control and Prevention (CDC) in NPHI development and strengthening of public health functions. We interviewed NPHI staff (N = 43), non-NPHI government staff (N = 29), and non-governmental organization staff (N = 24) in seven countries where CDC has supported NPHI development: Cambodia, Colombia, Liberia, Mozambique, Nigeria, Rwanda, and Zambia. Participants identified four areas of support that were the most important: workforce capacity building, technical assistance for key public health functions, identifying institutional gaps and priorities, and funding to support countries' priorities. Participants underscored the need for capacity building directed toward country-driven priorities during planning and implementation. Continued support for NPHI development from CDC and other partners is vital to building stronger public health systems, improving population health, and strengthening global health security., (© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.)
- Published
- 2021
- Full Text
- View/download PDF
165. Introduction to the Site-specific Etiologic Results From the Pneumonia Etiology Research for Child Health (PERCH) Study.
- Author
-
Deloria Knoll M, Prosperi C, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Howie SRC, Kotloff KL, Madhi SA, Murdoch DR, Scott JAG, Thea DM, and O'Brien KL
- Subjects
- AIDS-Related Opportunistic Infections diagnosis, AIDS-Related Opportunistic Infections epidemiology, AIDS-Related Opportunistic Infections etiology, AIDS-Related Opportunistic Infections prevention & control, Africa epidemiology, Age Factors, Asia epidemiology, Child, Preschool, Developing Countries, Health Policy, Hospitalization, Humans, Infant, Malnutrition complications, Patient Acuity, Pneumonia diagnosis, Pneumonia mortality, Pneumonia prevention & control, Risk Factors, Child Health, Pneumonia etiology
- Abstract
The Pneumonia Etiology Research for Child Health (PERCH) study evaluated the etiology of severe and very severe pneumonia in children hospitalized in 7 African and Asian countries. Here, we summarize the highlights of in-depth site-specific etiology analyses published separately in this issue, including how etiology varies by age, mortality status, malnutrition, severity, HIV status, and more. These site-specific results impart important lessons that can inform disease control policy implications., Competing Interests: M.D.K. has received funding for consultancies from Merck, Pfizer, Novartis, and grant funding from Merck. L.L.H. has received grant funding from GlaxoSmithKline, Pfizer and Merck. K.L.O. has received grant funding from GlaxoSmithKline and Pfizer and participated on technical advisory boards for Merck, Sanofi-Pasteur, PATH, Affinivax and ClearPath. C.P. has received grant funding from Merck. The other authors have no funding or conflicts of interest to disclose., (Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2021
- Full Text
- View/download PDF
166. Etiology and Clinical Characteristics of Severe Pneumonia Among Young Children in Thailand: Pneumonia Etiology Research for Child Health (PERCH) Case-Control Study Findings, 2012-2013.
- Author
-
Bunthi C, Rhodes J, Thamthitiwat S, Higdon MM, Chuananon S, Amorninthapichet T, Paveenkittiporn W, Chittaganpitch M, Sawatwong P, Hammitt LL, Feikin DR, Murdoch DR, Deloria-Knoll M, O'Brien KL, Prosperi C, Maloney SA, Baggett HC, and Akarasewi P
- Subjects
- AIDS-Related Opportunistic Infections diagnosis, AIDS-Related Opportunistic Infections epidemiology, AIDS-Related Opportunistic Infections etiology, AIDS-Related Opportunistic Infections prevention & control, Bayes Theorem, Case-Control Studies, Child Health, Child, Preschool, Developing Countries, Female, Hospitalization, Humans, Infant, Logistic Models, Male, Odds Ratio, Patient Acuity, Pneumonia epidemiology, Pneumonia prevention & control, Risk Factors, Thailand epidemiology, Pneumonia diagnosis, Pneumonia etiology
- Abstract
Background: Pneumonia remains the leading cause of death among children <5 years of age beyond the neonatal period in Thailand. Using data from the Pneumonia Etiology Research for Child Health (PERCH) Study, we provide a detailed description of pneumonia cases and etiology in Thailand to inform local treatment and prevention strategies in this age group., Methods: PERCH, a multi-country case-control study, evaluated the etiology of hospitalized cases of severe and very severe pneumonia among children 1-59 months of age. The Thailand site enrolled children for 24 consecutive months during January 2012-February 2014 with staggered start dates in 2 provinces. Cases were children hospitalized with pre-2013 WHO-defined severe or very severe pneumonia. Community controls were randomly selected from health services registries in each province. Analyses were restricted to HIV-negative cases and controls. We calculated adjusted odds ratios (ORs) and 95% CIs comparing organism prevalence detected by nasopharyngeal/oropharyngeal (NP/OP) polymerase chain reaction between cases and controls. The PERCH Integrated Analysis (PIA) used Bayesian latent variable analysis to estimate pathogen-specific etiologic fractions and 95% credible intervals., Results: Over 96% of both cases (n = 223) and controls (n = 659) had at least 1 organism detected; multiple organisms were detected in 86% of cases and 88% of controls. Among 98 chest Radiograph positive (CXR+) cases, respiratory syncytial virus (RSV) had the highest NP/OP prevalence (22.9%) and the strongest association with case status (OR 20.5; 95% CI: 10.2, 41.3) and accounted for 34.6% of the total etiologic fraction. Tuberculosis (TB) accounted for 10% (95% CrI: 1.6-26%) of the etiologic fraction among CXR+ cases., Discussion: More than one-third of hospitalized cases of severe and very severe CXR+ pneumonia among children 1-59 months of age in Thailand were attributable to RSV. TB accounted for 10% of cases, supporting evaluation for TB among children hospitalized with pneumonia in high-burden settings. Similarities in pneumonia etiology in Thailand and other PERCH sites suggest that global control strategies based on PERCH study findings are relevant to Thailand and similar settings., (Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2021
- Full Text
- View/download PDF
167. Upper Respiratory Tract Co-detection of Human Endemic Coronaviruses and High-density Pneumococcus Associated With Increased Severity Among HIV-Uninfected Children Under 5 Years Old in the PERCH Study.
- Author
-
Park DE, Higdon MM, Prosperi C, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Howie SRC, Kotloff KL, Levine OS, Madhi SA, Murdoch DR, O'Brien KL, Scott JAG, Thea DM, Antonio M, Awori JO, Baillie VL, Bunthi C, Kwenda G, Mackenzie GA, Moore DP, Morpeth SC, Mwananyanda L, Paveenkittiporn W, Ziaur Rahman M, Rahman M, Rhodes J, Sow SO, Tapia MD, and Deloria Knoll M
- Subjects
- Animals, COVID-19 diagnosis, COVID-19 epidemiology, COVID-19 virology, Child, Preschool, Coinfection diagnosis, Coinfection virology, Coronavirus, Coronavirus Infections epidemiology, Coronavirus Infections virology, Female, HIV Infections epidemiology, HIV Infections virology, Humans, Infant, Infant, Newborn, Logistic Models, Male, Nasopharynx virology, Pneumococcal Infections epidemiology, Pneumococcal Infections virology, Pneumonia diagnosis, Pneumonia virology, Respiratory Tract Infections epidemiology, Respiratory Tract Infections virology, SARS-CoV-2 isolation & purification, Streptococcus pneumoniae, Coinfection epidemiology, Coronavirus Infections diagnosis, Pneumococcal Infections diagnosis, Respiratory Tract Infections diagnosis
- Abstract
Background: Severity of viral respiratory illnesses can be increased with bacterial coinfection and can vary by sex, but influence of coinfection and sex on human endemic coronavirus (CoV) species, which generally cause mild to moderate respiratory illness, is unknown. We evaluated CoV and pneumococcal co-detection by sex in childhood pneumonia., Methods: In the 2011-2014 Pneumonia Etiology Research for Child Health study, nasopharyngeal and oropharyngeal (NP/OP) swabs and other samples were collected from 3981 children <5 years hospitalized with severe or very severe pneumonia in 7 countries. Severity by NP/OP detection status of CoV (NL63, 229E, OC43 or HKU1) and high-density (≥6.9 log10 copies/mL) pneumococcus (HDSpn) by real-time polymerase chain reaction was assessed by sex using logistic regression adjusted for age and site., Results: There were 43 (1.1%) CoV+/HDSpn+, 247 CoV+/HDSpn-, 449 CoV-/HDSpn+ and 3149 CoV-/HDSpn- cases with no significant difference in co-detection frequency by sex (range 51.2%-64.0% male, P = 0.06). More CoV+/HDSpn+ pneumonia was very severe compared with other groups for both males (13/22, 59.1% versus range 29.1%-34.7%, P = 0.04) and females (10/21, 47.6% versus 32.5%-43.5%, P = 0.009), but only male CoV+/HDSpn+ required supplemental oxygen more frequently (45.0% versus 20.6%-28.6%, P < 0.001) and had higher mortality (35.0% versus 5.3%-7.1%, P = 0.004) than other groups. For females with CoV+/HDSpn+, supplemental oxygen was 25.0% versus 24.8%-33.3% (P = 0.58) and mortality was 10.0% versus 9.2%-12.9% (P = 0.69)., Conclusions: Co-detection of endemic CoV and HDSpn was rare in children hospitalized with pneumonia, but associated with higher severity and mortality in males. Findings may warrant investigation of differences in severity by sex with co-detection of HDSpn and SARS-CoV-2., Competing Interests: J.A.G.S was supported by a clinical fellowship from the Wellcome Trust of Great Britain (UK; 098532). W.A.B. reported funding from Sanofi, PATH, Bill & Melinda Gates Foundation, and contributions to contemporaneous studies from Serum Institute of India, LTD, Roche and Sanofi. M.D.K. has received funding for consultancies from Merck, Pfizer, Novartis, and grant funding from Merck and Pfizer. M.M.H. has received grant funding from Pfizer. L.L.H. has received grant funding from GlaxoSmithKline, Pfizer and Merck. K.L.O. has received grant funding from GlaxoSmithKline and Pfizer and participates on technical advisory boards for Merck, Sanofi Pasteur, PATH, Affinivax and ClearPath. C.P. has received grant funding from Merck. S.R.C.H. has a patent Lipocalin-2 as a Biomarker for Pneumococcal Infection, Status pending. K.L.K. has received grant funding from Merck Sharp & Dohme. S.A.M. has received honorarium for advisory board from the Bill & Melinda Gates Foundation, Pfizer, Medimmune and Novartis; institutional grants from GlaxoSmithKline, Novartis, Pfizer, Minervax and Bill & Melinda Gates Foundation; and speakers bureau for Sanofi Pasteur and GlaxoSmithKline. This paper is published with the permission of the Director of the Kenya Medical Research Institute. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, Department of Health and Human Services, or the US government. The other authors have no conflicts of interest to disclose., (Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2021
- Full Text
- View/download PDF
168. The Global Field Epidemiology Roadmap: Enhancing Global Health Security by Accelerating the Development of Field Epidemiology Capacity Worldwide.
- Author
-
O'Carroll PW, Kirk MD, Reddy C, Morgan OW, and Baggett HC
- Subjects
- COVID-19, Disease Outbreaks, Epidemiologic Methods, Epidemiological Monitoring, Humans, Public Health methods, Public Health Administration, Epidemiology education, Global Health, Public Health education
- Published
- 2021
- Full Text
- View/download PDF
169. Community-Associated Outbreak of COVID-19 in a Correctional Facility - Utah, September 2020-January 2021.
- Author
-
Lewis NM, Salmanson AP, Price A, Risk I, Guymon C, Wisner M, Gardner K, Fukunaga R, Schwitters A, Lambert L, Baggett HC, Ewetola R, and Dunn AC
- Subjects
- COVID-19 prevention & control, COVID-19 Testing, Community-Acquired Infections, Humans, Mass Screening, Quarantine, SARS-CoV-2 isolation & purification, Utah epidemiology, COVID-19 epidemiology, COVID-19 transmission, Dentists, Disease Outbreaks, Infectious Disease Transmission, Professional-to-Patient, Prisons
- Abstract
Transmission of SARS-CoV-2, the virus that causes COVID-19, is common in congregate settings such as correctional and detention facilities (1-3). On September 17, 2020, a Utah correctional facility (facility A) received a report of laboratory-confirmed SARS-CoV-2 infection in a dental health care provider (DHCP) who had treated incarcerated persons at facility A on September 14, 2020 while asymptomatic. On September 21, 2020, the roommate of an incarcerated person who had received dental treatment experienced COVID-19-compatible symptoms*; both were housed in block 1 of facility A (one of 16 occupied blocks across eight residential units). Two days later, the roommate received a positive SARS-CoV-2 test result, becoming the first person with a known-associated case of COVID-19 at facility A. During September 23-24, 2020, screening of 10 incarcerated persons who had received treatment from the DHCP identified another two persons with COVID-19, prompting isolation of all three patients in an unoccupied block at the facility. Within block 1, group activities were stopped to limit interaction among staff members and incarcerated persons and prevent further spread. During September 14-24, 2020, six facility A staff members, one of whom had previous close contact
† with one of the patients, also reported symptoms. On September 27, 2020, an outbreak was confirmed after specimens from all remaining incarcerated persons in block 1 were tested; an additional 46 cases of COVID-19 were identified, which were reported to the Salt Lake County Health Department and the Utah Department of Health. On September 30, 2020, CDC, in collaboration with both health departments and the correctional facility, initiated an investigation to identify factors associated with the outbreak and implement control measures. As of January 31, 2021, a total of 1,368 cases among 2,632 incarcerated persons (attack rate = 52%) and 88 cases among 550 staff members (attack rate = 16%) were reported in facility A. Among 33 hospitalized incarcerated persons, 11 died. Quarantine and monitoring of potentially exposed persons and implementation of available prevention measures, including vaccination, are important in preventing introduction and spread of SARS-CoV-2 in correctional facilities and other congregate settings (4)., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.- Published
- 2021
- Full Text
- View/download PDF
170. Konzo outbreak in the Western Province of Zambia.
- Author
-
Siddiqi OK, Kapina M, Kumar R, Ngomah Moraes A, Kabwe P, Mazaba ML, Hachaambwa L, Ng'uni NM, Chikoti PC, Morel-Espinosa M, Jarrett JM, Baggett HC, and Chizema-Kawesha E
- Subjects
- Adolescent, Age Factors, Breast Feeding, Child, Cyanides analysis, Diet, Disease Outbreaks, Female, Humans, Male, Manihot chemistry, Muscle Weakness epidemiology, Muscle Weakness etiology, Protein Deficiency epidemiology, Rain, Seasons, Thiocyanates urine, Young Adult, Zambia epidemiology, Paraparesis, Spastic epidemiology
- Abstract
Objective: To identify the etiology of an outbreak of spastic paraparesis among women and children in the Western Province of Zambia suspected to be konzo., Methods: We conducted an outbreak investigation of individuals from Mongu District, Western Province, Zambia, who previously developed lower extremity weakness. Cases were classified with the World Health Organization definition of konzo. Active case finding was conducted through door-to-door evaluation in affected villages and sensitization at local health clinics. Demographic, medical, and dietary history was used to identify common exposures in all cases. Urine and blood specimens were taken to evaluate for konzo and alternative etiologies., Results: We identified 32 cases of konzo exclusively affecting children 6 to 14 years of age and predominantly females >14 years of age. Fourteen of 15 (93%) cases ≥15 years of age were female, 11 (73%) of whom were breastfeeding at the time of symptom onset. Cassava was the most commonly consumed food (median [range] 14 [4-21] times per week), while protein-rich foods were consumed <1 time per week for all cases. Of the 30 patients providing urine specimens, median thiocyanate level was 281 (interquartile range 149-522) μmol/L, and 73% of urine samples had thiocyanate levels >136 μmol/L, the 95th percentile of the US population in 2013 to 2014., Conclusion: This investigation revealed the first documented cases of konzo in Zambia, occurring in poor communities with diets high in cassava and low in protein, consistent with previous descriptions from neighboring countries., (© 2020 American Academy of Neurology.)
- Published
- 2020
- Full Text
- View/download PDF
171. Enhanced surveillance for severe pneumonia, Thailand 2010-2015.
- Author
-
Bunthi C, Baggett HC, Gregory CJ, Thamthitiwat S, Yingyong T, Paveenkittiporn W, Kerdsin A, Chittaganpitch M, Ruangchira-Urai R, Akarasewi P, and Ungchusak K
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Community-Acquired Infections microbiology, Female, Hospitalization, Hospitals statistics & numerical data, Humans, Infant, Male, Middle Aged, Middle East Respiratory Syndrome Coronavirus, Pneumonia microbiology, Respiratory Syncytial Virus, Human, Thailand epidemiology, Young Adult, Community-Acquired Infections epidemiology, Disease Outbreaks statistics & numerical data, Pneumonia epidemiology, Population Surveillance methods
- Abstract
Background: The etiology of severe pneumonia is frequently not identified by routine disease surveillance in Thailand. Since 2010, the Thailand Ministry of Public Health (MOPH) and US CDC have conducted surveillance to detect known and new etiologies of severe pneumonia., Methods: Surveillance for severe community-acquired pneumonia was initiated in December 2010 among 30 hospitals in 17 provinces covering all regions of Thailand. Interlinked clinical, laboratory, pathological and epidemiological components of the network were created with specialized guidelines for each to aid case investigation and notification. Severe pneumonia was defined as chest-radiograph confirmed pneumonia of unknown etiology in a patient hospitalized ≤48 h and requiring intubation with ventilator support or who died within 48 h after hospitalization; patients with underlying chronic pulmonary or neurological disease were excluded. Respiratory and pathological specimens were tested by reverse transcription polymerase chain reaction for nine viruses, including Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and 14 bacteria. Cases were reported via a secure web-based system., Results: Of specimens from 972 cases available for testing during December 2010 through December 2015, 589 (60.6%) had a potential etiology identified; 399 (67.8%) were from children aged < 5 years. At least one viral agent was detected in 394 (40.5%) cases, with the most common of single vial pathogen detected being respiratory syncytial virus (RSV) (110/589, 18.7%) especially in children under 5 years. Bacterial pathogens were detected in 341 cases of which 67 cases had apparent mixed infections. The system added MERS-CoV testing in September 2012 as part of Thailand's outbreak preparedness; no cases were identified from the 767 samples tested., Conclusions: Enhanced surveillance improved the understanding of the etiology of severe pneumonia cases and improved the MOPH's preparedness and response capacity for emerging respiratory pathogens in Thailand thereby enhanced global health security. Guidelines for investigation of severe pneumonia from this project were incorporated into surveillance and research activities within Thailand and shared for adaption by other countries.
- Published
- 2019
- Full Text
- View/download PDF
172. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.
- Author
-
Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, Polack FP, Balsells E, Acacio S, Aguayo C, Alassani I, Ali A, Antonio M, Awasthi S, Awori JO, Azziz-Baumgartner E, Baggett HC, Baillie VL, Balmaseda A, Barahona A, Basnet S, Bassat Q, Basualdo W, Bigogo G, Bont L, Breiman RF, Brooks WA, Broor S, Bruce N, Bruden D, Buchy P, Campbell S, Carosone-Link P, Chadha M, Chipeta J, Chou M, Clara W, Cohen C, de Cuellar E, Dang DA, Dash-Yandag B, Deloria-Knoll M, Dherani M, Eap T, Ebruke BE, Echavarria M, de Freitas Lázaro Emediato CC, Fasce RA, Feikin DR, Feng L, Gentile A, Gordon A, Goswami D, Goyet S, Groome M, Halasa N, Hirve S, Homaira N, Howie SRC, Jara J, Jroundi I, Kartasasmita CB, Khuri-Bulos N, Kotloff KL, Krishnan A, Libster R, Lopez O, Lucero MG, Lucion F, Lupisan SP, Marcone DN, McCracken JP, Mejia M, Moisi JC, Montgomery JM, Moore DP, Moraleda C, Moyes J, Munywoki P, Mutyara K, Nicol MP, Nokes DJ, Nymadawa P, da Costa Oliveira MT, Oshitani H, Pandey N, Paranhos-Baccalà G, Phillips LN, Picot VS, Rahman M, Rakoto-Andrianarivelo M, Rasmussen ZA, Rath BA, Robinson A, Romero C, Russomando G, Salimi V, Sawatwong P, Scheltema N, Schweiger B, Scott JAG, Seidenberg P, Shen K, Singleton R, Sotomayor V, Strand TA, Sutanto A, Sylla M, Tapia MD, Thamthitiwat S, Thomas ED, Tokarz R, Turner C, Venter M, Waicharoen S, Wang J, Watthanaworawit W, Yoshida LM, Yu H, Zar HJ, Campbell H, and Nair H
- Subjects
- Child, Preschool, Developing Countries, Global Health, Hospital Mortality, Humans, Incidence, Infant, Infant, Newborn, Risk Factors, Hospitalization statistics & numerical data, Models, Statistical, Respiratory Syncytial Viruses isolation & purification, Respiratory Tract Infections epidemiology
- Abstract
Background: We have previously estimated that respiratory syncytial virus (RSV) was associated with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in 55 000 to 199 000 deaths in children younger than 5 years in 2005. In the past 5 years, major research activity on RSV has yielded substantial new data from developing countries. With a considerably expanded dataset from a large international collaboration, we aimed to estimate the global incidence, hospital admission rate, and mortality from RSV-ALRI episodes in young children in 2015., Methods: We estimated the incidence and hospital admission rate of RSV-associated ALRI (RSV-ALRI) in children younger than 5 years stratified by age and World Bank income regions from a systematic review of studies published between Jan 1, 1995, and Dec 31, 2016, and unpublished data from 76 high quality population-based studies. We estimated the RSV-ALRI incidence for 132 developing countries using a risk factor-based model and 2015 population estimates. We estimated the in-hospital RSV-ALRI mortality by combining in-hospital case fatality ratios with hospital admission estimates from hospital-based (published and unpublished) studies. We also estimated overall RSV-ALRI mortality by identifying studies reporting monthly data for ALRI mortality in the community and RSV activity., Findings: We estimated that globally in 2015, 33·1 million (uncertainty range [UR] 21·6-50·3) episodes of RSV-ALRI, resulted in about 3·2 million (2·7-3·8) hospital admissions, and 59 600 (48 000-74 500) in-hospital deaths in children younger than 5 years. In children younger than 6 months, 1·4 million (UR 1·2-1·7) hospital admissions, and 27 300 (UR 20 700-36 200) in-hospital deaths were due to RSV-ALRI. We also estimated that the overall RSV-ALRI mortality could be as high as 118 200 (UR 94 600-149 400). Incidence and mortality varied substantially from year to year in any given population., Interpretation: Globally, RSV is a common cause of childhood ALRI and a major cause of hospital admissions in young children, resulting in a substantial burden on health-care services. About 45% of hospital admissions and in-hospital deaths due to RSV-ALRI occur in children younger than 6 months. An effective maternal RSV vaccine or monoclonal antibody could have a substantial effect on disease burden in this age group., Funding: The Bill & Melinda Gates Foundation., (Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
173. Standardization of Laboratory Methods for the PERCH Study.
- Author
-
Driscoll AJ, Karron RA, Morpeth SC, Bhat N, Levine OS, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Howie SRC, Knoll MD, Kotloff KL, Madhi SA, Scott JAG, Thea DM, Adrian PV, Ahmed D, Alam M, Anderson TP, Antonio M, Baillie VL, Dione M, Endtz HP, Gitahi C, Karani A, Kwenda G, Maiga AA, McClellan J, Mitchell JL, Morailane P, Mugo D, Mwaba J, Mwansa J, Mwarumba S, Nyongesa S, Panchalingam S, Rahman M, Sawatwong P, Tamboura B, Toure A, Whistler T, O'Brien KL, and Murdoch DR
- Subjects
- Algorithms, Child, Preschool, Data Accuracy, Female, HIV Infections, Humans, Infant, Male, Pneumonia, Bacterial diagnosis, Pneumonia, Viral diagnosis, Quality Control, Reference Standards, Respiratory Tract Infections etiology, Clinical Laboratory Techniques standards, Pneumonia diagnosis, Pneumonia etiology, Specimen Handling standards
- Abstract
The Pneumonia Etiology Research for Child Health study was conducted across 7 diverse research sites and relied on standardized clinical and laboratory methods for the accurate and meaningful interpretation of pneumonia etiology data. Blood, respiratory specimens, and urine were collected from children aged 1-59 months hospitalized with severe or very severe pneumonia and community controls of the same age without severe pneumonia and were tested with an extensive array of laboratory diagnostic tests. A standardized testing algorithm and standard operating procedures were applied across all study sites. Site laboratories received uniform training, equipment, and reagents for core testing methods. Standardization was further assured by routine teleconferences, in-person meetings, site monitoring visits, and internal and external quality assurance testing. Targeted confirmatory testing and testing by specialized assays were done at a central reference laboratory., (© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2017
- Full Text
- View/download PDF
174. Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged <5 Years in the PERCH Study.
- Author
-
Higdon MM, Le T, O'Brien KL, Murdoch DR, Prosperi C, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Howie SRC, Kotloff KL, Levine OS, Scott JAG, Thea DM, Awori JO, Baillie VL, Cascio S, Chuananon S, DeLuca AN, Driscoll AJ, Ebruke BE, Endtz HP, Kaewpan A, Kahn G, Karani A, Karron RA, Moore DP, Park DE, Rahman MZ, Salaudeen R, Seidenberg P, Somwe SW, Sylla M, Tapia MD, Zeger SL, Deloria Knoll M, and Madhi SA
- Subjects
- Bacteria genetics, Bacteria isolation & purification, Biomarkers blood, Case-Control Studies, Child, Preschool, Community-Acquired Infections diagnosis, Female, Humans, Infant, Infant, Newborn, Male, Nasopharynx virology, Oropharynx virology, Pneumonia, Bacterial microbiology, Pneumonia, Viral virology, Polymerase Chain Reaction, ROC Curve, Respiratory Syncytial Virus Infections blood, Respiratory Syncytial Virus, Human genetics, Respiratory Syncytial Virus, Human isolation & purification, Sensitivity and Specificity, C-Reactive Protein analysis, Pneumonia, Bacterial diagnosis, Pneumonia, Viral diagnosis
- Abstract
Background.: Lack of a gold standard for identifying bacterial and viral etiologies of pneumonia has limited evaluation of C-reactive protein (CRP) for identifying bacterial pneumonia. We evaluated the sensitivity and specificity of CRP for identifying bacterial vs respiratory syncytial virus (RSV) pneumonia in the Pneumonia Etiology Research for Child Health (PERCH) multicenter case-control study., Methods.: We measured serum CRP levels in cases with World Health Organization-defined severe or very severe pneumonia and a subset of community controls. We evaluated the sensitivity and specificity of elevated CRP for "confirmed" bacterial pneumonia (positive blood culture or positive lung aspirate or pleural fluid culture or polymerase chain reaction [PCR]) compared to "RSV pneumonia" (nasopharyngeal/oropharyngeal or induced sputum PCR-positive without confirmed/suspected bacterial pneumonia). Receiver operating characteristic (ROC) curves were constructed to assess the performance of elevated CRP in distinguishing these cases., Results.: Among 601 human immunodeficiency virus (HIV)-negative tested controls, 3% had CRP ≥40 mg/L. Among 119 HIV-negative cases with confirmed bacterial pneumonia, 77% had CRP ≥40 mg/L compared with 17% of 556 RSV pneumonia cases. The ROC analysis produced an area under the curve of 0.87, indicating very good discrimination; a cut-point of 37.1 mg/L best discriminated confirmed bacterial pneumonia (sensitivity 77%) from RSV pneumonia (specificity 82%). CRP ≥100 mg/L substantially improved specificity over CRP ≥40 mg/L, though at a loss to sensitivity., Conclusions.: Elevated CRP was positively associated with confirmed bacterial pneumonia and negatively associated with RSV pneumonia in PERCH. CRP may be useful for distinguishing bacterial from RSV-associated pneumonia, although its role in discriminating against other respiratory viral-associated pneumonia needs further study., (© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2017
- Full Text
- View/download PDF
175. Is Higher Viral Load in the Upper Respiratory Tract Associated With Severe Pneumonia? Findings From the PERCH Study.
- Author
-
Feikin DR, Fu W, Park DE, Shi Q, Higdon MM, Baggett HC, Brooks WA, Deloria Knoll M, Hammitt LL, Howie SRC, Kotloff KL, Levine OS, Madhi SA, Scott JAG, Thea DM, Adrian PV, Antonio M, Awori JO, Baillie VL, DeLuca AN, Driscoll AJ, Ebruke BE, Goswami D, Karron RA, Li M, Morpeth SC, Mwaba J, Mwansa J, Prosperi C, Sawatwong P, Sow SO, Tapia MD, Whistler T, Zaman K, Zeger SL, O' Brien KL, and Murdoch DR
- Subjects
- Case-Control Studies, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Internationality, Logistic Models, Male, Nasopharynx virology, Oropharynx virology, Pneumonia, Viral diagnostic imaging, ROC Curve, Respiratory Syncytial Virus Infections virology, Respiratory Syncytial Viruses growth & development, Respiratory Syncytial Viruses isolation & purification, Respiratory Tract Infections microbiology, Viruses growth & development, Viruses isolation & purification, World Health Organization, Pneumonia, Viral diagnosis, Pneumonia, Viral virology, Respiratory Tract Infections virology, Viral Load
- Abstract
Background.: The etiologic inference of identifying a pathogen in the upper respiratory tract (URT) of children with pneumonia is unclear. To determine if viral load could provide evidence of causality of pneumonia, we compared viral load in the URT of children with World Health Organization-defined severe and very severe pneumonia and age-matched community controls., Methods.: In the 9 developing country sites, nasopharyngeal/oropharyngeal swabs from children with and without pneumonia were tested using quantitative real-time polymerase chain reaction for 17 viruses. The association of viral load with case status was evaluated using logistic regression. Receiver operating characteristic (ROC) curves were constructed to determine optimal discriminatory viral load cutoffs. Viral load density distributions were plotted., Results.: The mean viral load was higher in cases than controls for 7 viruses. However, there was substantial overlap in viral load distribution of cases and controls for all viruses. ROC curves to determine the optimal viral load cutoff produced an area under the curve of <0.80 for all viruses, suggesting poor to fair discrimination between cases and controls. Fatal and very severe pneumonia cases did not have higher viral load than less severe cases for most viruses., Conclusions.: Although we found higher viral loads among pneumonia cases than controls for some viruses, the utility in using viral load of URT specimens to define viral pneumonia was equivocal. Our analysis was limited by lack of a gold standard for viral pneumonia., (© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2017
- Full Text
- View/download PDF
176. Introduction to the Epidemiologic Considerations, Analytic Methods, and Foundational Results From the Pneumonia Etiology Research for Child Health Study.
- Author
-
O'Brien KL, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Howie SRC, Deloria Knoll M, Kotloff KL, Levine OS, Madhi SA, Murdoch DR, Scott JAG, Thea DM, and Zeger SL
- Subjects
- Epidemiologic Methods, Humans, Pneumonia mortality, Survival Analysis, Child Health, Global Health, Pneumonia epidemiology, Pneumonia etiology
- Published
- 2017
- Full Text
- View/download PDF
177. Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii.
- Author
-
Park DE, Baggett HC, Howie SRC, Shi Q, Watson NL, Brooks WA, Deloria Knoll M, Hammitt LL, Kotloff KL, Levine OS, Madhi SA, Murdoch DR, O'Brien KL, Scott JAG, Thea DM, Ahmed D, Antonio M, Baillie VL, DeLuca AN, Driscoll AJ, Fu W, Gitahi CW, Olutunde E, Higdon MM, Hossain L, Karron RA, Maiga AA, Maloney SA, Moore DP, Morpeth SC, Mwaba J, Mwenechanya M, Prosperi C, Sylla M, Thamthitiwat S, Zeger SL, and Feikin DR
- Subjects
- Child, Preschool, Female, Haemophilus Infections diagnosis, Haemophilus Infections microbiology, Haemophilus influenzae genetics, Haemophilus influenzae isolation & purification, Humans, Infant, Male, Moraxella catarrhalis genetics, Moraxella catarrhalis isolation & purification, Moraxellaceae Infections diagnosis, Moraxellaceae Infections microbiology, Nasopharynx microbiology, Oropharynx microbiology, Pneumocystis carinii genetics, Pneumocystis carinii isolation & purification, Pneumonia, Bacterial diagnostic imaging, Pneumonia, Bacterial etiology, Pneumonia, Bacterial microbiology, Pneumonia, Pneumocystis microbiology, Pneumonia, Staphylococcal diagnosis, Pneumonia, Staphylococcal microbiology, Polymerase Chain Reaction, ROC Curve, Staphylococcus aureus genetics, Staphylococcus aureus isolation & purification, Haemophilus influenzae growth & development, Moraxella catarrhalis growth & development, Pneumocystis carinii growth & development, Pneumonia, Bacterial diagnosis, Pneumonia, Pneumocystis diagnosis, Respiratory Tract Infections microbiology, Staphylococcus aureus growth & development
- Abstract
Background.: There is limited information on the association between colonization density of upper respiratory tract colonizers and pathogen-specific pneumonia. We assessed this association for Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii., Methods.: In 7 low- and middle-income countries, nasopharyngeal/oropharyngeal swabs from children with severe pneumonia and age-frequency matched community controls were tested using quantitative polymerase chain reaction (PCR). Differences in median colonization density were evaluated using the Wilcoxon rank-sum test. Density cutoffs were determined using receiver operating characteristic curves. Cases with a pathogen identified from lung aspirate culture or PCR, pleural fluid culture or PCR, blood culture, and immunofluorescence for P. jirovecii defined microbiologically confirmed cases for the given pathogens., Results.: Higher densities of H. influenzae were observed in both microbiologically confirmed cases and chest radiograph (CXR)-positive cases compared to controls. Staphylococcus aureus and P. jirovecii had higher densities in CXR-positive cases vs controls. A 5.9 log10 copies/mL density cutoff for H. influenzae yielded 86% sensitivity and 77% specificity for detecting microbiologically confirmed cases; however, densities overlapped between cases and controls and positive predictive values were poor (<3%). Informative density cutoffs were not found for S. aureus and M. catarrhalis, and a lack of confirmed case data limited the cutoff identification for P. jirovecii., Conclusions.: There is evidence for an association between H. influenzae colonization density and H. influenzae-confirmed pneumonia in children; the association may be particularly informative in epidemiologic studies. Colonization densities of M. catarrhalis, S. aureus, and P. jirovecii are unlikely to be of diagnostic value in clinical settings., (© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2017
- Full Text
- View/download PDF
178. Safety of Induced Sputum Collection in Children Hospitalized With Severe or Very Severe Pneumonia.
- Author
-
DeLuca AN, Hammitt LL, Kim J, Higdon MM, Baggett HC, Brooks WA, Howie SRC, Deloria Knoll M, Kotloff KL, Levine OS, Madhi SA, Murdoch DR, Scott JAG, Thea DM, Amornintapichet T, Awori JO, Chuananon S, Driscoll AJ, Ebruke BE, Hossain L, Jahan Y, Kagucia EW, Kazungu S, Moore DP, Mudau A, Mwananyanda L, Park DE, Prosperi C, Seidenberg P, Sylla M, Tapia MD, Zaman SMA, and O'Brien KL
- Subjects
- Bacteria isolation & purification, Child, Preschool, Female, Humans, Infant, Male, Oxygen, Poverty, Specimen Handling methods, Pneumonia diagnosis, Pneumonia etiology, Specimen Handling adverse effects, Sputum
- Abstract
Background.: Induced sputum (IS) may provide diagnostic information about the etiology of pneumonia. The safety of this procedure across a heterogeneous population with severe pneumonia in low- and middle-income countries has not been described., Methods.: IS specimens were obtained as part a 7-country study of the etiology of severe and very severe pneumonia in hospitalized children <5 years of age. Rigorous clinical monitoring was done before, during, and after the procedure to record oxygen requirement, oxygen saturation, respiratory rate, consciousness level, and other evidence of clinical deterioration. Criteria for IS contraindications were predefined and serious adverse events (SAEs) were reported to ethics committees and a central safety monitor., Results.: A total of 4653 IS procedures were done among 3802 children. Thirteen SAEs were reported in relation to collection of IS, or 0.34% of children with at least 1 IS specimen collected (95% confidence interval, 0.15%-0.53%). A drop in oxygen saturation that required supplemental oxygen was the most common SAE. One child died after feeding was reinitiated 2 hours after undergoing sputum induction; this death was categorized as "possibly related" to the procedure., Conclusions.: The overall frequency of SAEs was very low, and the nature of most SAEs was manageable, demonstrating a low-risk safety profile for IS collection even among severely ill children in low-income-country settings. Healthcare providers should monitor oxygen saturation and requirements during and after IS collection, and assess patients prior to reinitiating feeding after the IS procedure, to ensure patient safety., (© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2017
- Full Text
- View/download PDF
179. Standardization of Clinical Assessment and Sample Collection Across All PERCH Study Sites.
- Author
-
Crawley J, Prosperi C, Baggett HC, Brooks WA, Deloria Knoll M, Hammitt LL, Howie SRC, Kotloff KL, Levine OS, Madhi SA, Murdoch DR, O'Brien KL, Thea DM, Awori JO, Bunthi C, DeLuca AN, Driscoll AJ, Ebruke BE, Goswami D, Hidgon MM, Karron RA, Kazungu S, Kourouma N, Mackenzie G, Moore DP, Mudau A, Mwale M, Nahar K, Park DE, Piralam B, Seidenberg P, Sylla M, Feikin DR, and Scott JAG
- Subjects
- Bangladesh, Child, Data Interpretation, Statistical, Epidemiologic Research Design, Female, Gambia, Hospitals, Humans, Internationality, Kenya, Male, Mali, Multicenter Studies as Topic standards, Pneumonia drug therapy, Pneumonia prevention & control, Pneumonia, Bacterial diagnosis, Pneumonia, Bacterial epidemiology, Pneumonia, Viral diagnosis, Pneumonia, Viral epidemiology, South Africa, Thailand, Zambia, Clinical Laboratory Techniques standards, Pneumonia diagnosis, Pneumonia etiology, Specimen Handling standards
- Abstract
Background.: Variable adherence to standardized case definitions, clinical procedures, specimen collection techniques, and laboratory methods has complicated the interpretation of previous multicenter pneumonia etiology studies. To circumvent these problems, a program of clinical standardization was embedded in the Pneumonia Etiology Research for Child Health (PERCH) study., Methods.: Between March 2011 and August 2013, standardized training on the PERCH case definition, clinical procedures, and collection of laboratory specimens was delivered to 331 clinical staff at 9 study sites in 7 countries (The Gambia, Kenya, Mali, South Africa, Zambia, Thailand, and Bangladesh), through 32 on-site courses and a training website. Staff competency was assessed throughout 24 months of enrollment with multiple-choice question (MCQ) examinations, a video quiz, and checklist evaluations of practical skills., Results.: MCQ evaluation was confined to 158 clinical staff members who enrolled PERCH cases and controls, with scores obtained for >86% of eligible staff at each time-point. Median scores after baseline training were ≥80%, and improved by 10 percentage points with refresher training, with no significant intersite differences. Percentage agreement with the clinical trainer on the presence or absence of clinical signs on video clips was high (≥89%), with interobserver concordance being substantial to high (AC1 statistic, 0.62-0.82) for 5 of 6 signs assessed. Staff attained median scores of >90% in checklist evaluations of practical skills., Conclusions.: Satisfactory clinical standardization was achieved within and across all PERCH sites, providing reassurance that any etiological or clinical differences observed across the study sites are true differences, and not attributable to differences in application of the clinical case definition, interpretation of clinical signs, or in techniques used for clinical measurements or specimen collection., (© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2017
- Full Text
- View/download PDF
180. Evaluation of Pneumococcal Load in Blood by Polymerase Chain Reaction for the Diagnosis of Pneumococcal Pneumonia in Young Children in the PERCH Study.
- Author
-
Deloria Knoll M, Morpeth SC, Scott JAG, Watson NL, Park DE, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Howie SRC, Kotloff KL, Levine OS, O'Brien KL, Thea DM, Ahmed D, Antonio M, Awori JO, Baillie VL, Chipeta J, Deluca AN, Dione M, Driscoll AJ, Higdon MM, Jatapai A, Karron RA, Mazumder R, Moore DP, Mwansa J, Nyongesa S, Prosperi C, Seidenberg P, Siludjai D, Sow SO, Tamboura B, Zeger SL, Murdoch DR, and Madhi SA
- Subjects
- Case-Control Studies, Child, Preschool, Female, Genes, Bacterial, Humans, Infant, Infant, Newborn, Internationality, Male, Nasopharynx microbiology, Real-Time Polymerase Chain Reaction methods, Streptococcus pneumoniae genetics, Streptococcus pneumoniae isolation & purification, Bacterial Load, DNA, Bacterial blood, Pneumonia, Pneumococcal diagnosis, Pneumonia, Pneumococcal microbiology, Streptococcus pneumoniae physiology
- Abstract
Background.: Detection of pneumococcus by lytA polymerase chain reaction (PCR) in blood had poor diagnostic accuracy for diagnosing pneumococcal pneumonia in children in 9 African and Asian sites. We assessed the value of blood lytA quantification in diagnosing pneumococcal pneumonia., Methods.: The Pneumonia Etiology Research for Child Health (PERCH) case-control study tested whole blood by PCR for pneumococcus in children aged 1-59 months hospitalized with signs of pneumonia and in age-frequency matched community controls. The distribution of load among PCR-positive participants was compared between microbiologically confirmed pneumococcal pneumonia (MCPP) cases, cases confirmed for nonpneumococcal pathogens, nonconfirmed cases, and controls. Receiver operating characteristic analyses determined the "optimal threshold" that distinguished MCPP cases from controls., Results.: Load was available for 290 of 291 cases with pneumococcal PCR detected in blood and 273 of 273 controls. Load was higher in MCPP cases than controls (median, 4.0 × 103 vs 0.19 × 103 copies/mL), but overlapped substantially (range, 0.16-989.9 × 103 copies/mL and 0.01-551.9 × 103 copies/mL, respectively). The proportion with high load (≥2.2 log10 copies/mL) was 62.5% among MCPP cases, 4.3% among nonconfirmed cases, 9.3% among cases confirmed for a nonpneumococcal pathogen, and 3.1% among controls. Pneumococcal load in blood was not associated with respiratory tract illness in controls (P = .32). High blood pneumococcal load was associated with alveolar consolidation on chest radiograph in nonconfirmed cases, and with high (>6.9 log10 copies/mL) nasopharyngeal/oropharyngeal load and C-reactive protein ≥40 mg/L (both P < .01) in nonconfirmed cases but not controls., Conclusions.: Quantitative pneumococcal PCR in blood has limited diagnostic utility for identifying pneumococcal pneumonia in individual children, but may be informative in epidemiological studies., (© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2017
- Full Text
- View/download PDF
181. Microscopic Analysis and Quality Assessment of Induced Sputum From Children With Pneumonia in the PERCH Study.
- Author
-
Murdoch DR, Morpeth SC, Hammitt LL, Driscoll AJ, Watson NL, Baggett HC, Brooks WA, Deloria Knoll M, Feikin DR, Kotloff KL, Levine OS, Madhi SA, O'Brien KL, Scott JAG, Thea DM, Ahmed D, Awori JO, DeLuca AN, Ebruke BE, Higdon MM, Jorakate P, Karron RA, Kazungu S, Kwenda G, Hossain L, Makprasert S, Moore DP, Mudau A, Mwaba J, Panchalingam S, Park DE, Prosperi C, Salaudeen R, Toure A, Zeger SL, and Howie SRC
- Subjects
- Bacteria isolation & purification, Bacteria ultrastructure, Child Health, Child, Preschool, Community-Acquired Infections diagnosis, Community-Acquired Infections etiology, Epithelial Cells ultrastructure, Female, Hospitalization, Humans, Infant, Infant, Newborn, Male, Neutrophils ultrastructure, Pneumonia, Bacterial microbiology, Respiratory Tract Infections diagnosis, Respiratory Tract Infections microbiology, Saliva cytology, Saliva microbiology, Specimen Handling, Pneumonia diagnosis, Pneumonia etiology, Pneumonia microbiology, Pneumonia, Bacterial diagnosis, Sputum cytology, Sputum microbiology
- Abstract
Background.: It is standard practice for laboratories to assess the cellular quality of expectorated sputum specimens to check that they originated from the lower respiratory tract. The presence of low numbers of squamous epithelial cells (SECs) and high numbers of polymorphonuclear (PMN) cells are regarded as indicative of a lower respiratory tract specimen. However, these quality ratings have never been evaluated for induced sputum specimens from children with suspected pneumonia., Methods.: We evaluated induced sputum Gram stain smears and cultures from hospitalized children aged 1-59 months enrolled in a large study of community-acquired pneumonia. We hypothesized that a specimen representative of the lower respiratory tract will contain smaller quantities of oropharyngeal flora and be more likely to have a predominance of potential pathogens compared to a specimen containing mainly saliva. The prevalence of potential pathogens cultured from induced sputum specimens and quantity of oropharyngeal flora were compared for different quantities of SECs and PMNs., Results.: Of 3772 induced sputum specimens, 2608 (69%) had <10 SECs per low-power field (LPF) and 2350 (62%) had >25 PMNs per LPF, measures traditionally associated with specimens from the lower respiratory tract in adults. Using isolation of low quantities of oropharyngeal flora and higher prevalence of potential pathogens as markers of higher quality, <10 SECs per LPF (but not >25 PMNs per LPF) was the microscopic variable most associated with high quality of induced sputum., Conclusions.: Quantity of SECs may be a useful quality measure of induced sputum from young children with pneumonia., (© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2017
- Full Text
- View/download PDF
182. Should Controls With Respiratory Symptoms Be Excluded From Case-Control Studies of Pneumonia Etiology? Reflections From the PERCH Study.
- Author
-
Higdon MM, Hammitt LL, Deloria Knoll M, Baggett HC, Brooks WA, Howie SRC, Kotloff KL, Levine OS, Madhi SA, Murdoch DR, Scott JAG, Thea DM, Driscoll AJ, Karron RA, Park DE, Prosperi C, Zeger SL, O'Brien KL, and Feikin DR
- Subjects
- Child, Data Interpretation, Statistical, Female, Humans, Male, Multicenter Studies as Topic, Pneumonia epidemiology, Pneumonia, Bacterial epidemiology, Pneumonia, Viral epidemiology, Risk Factors, Selection Bias, Epidemiologic Research Design, Pneumonia etiology, Research Design, Respiratory Tract Infections diagnosis, Respiratory Tract Infections etiology
- Abstract
Many pneumonia etiology case-control studies exclude controls with respiratory illness from enrollment or analyses. Herein we argue that selecting controls regardless of respiratory symptoms provides the least biased estimates of pneumonia etiology. We review 3 reasons investigators may choose to exclude controls with respiratory symptoms in light of epidemiologic principles of control selection and present data from the Pneumonia Etiology Research for Child Health (PERCH) study where relevant to assess their validity. We conclude that exclusion of controls with respiratory symptoms will result in biased estimates of etiology. Randomly selected community controls, with or without respiratory symptoms, as long as they do not meet the criteria for case-defining pneumonia, are most representative of the general population from which cases arose and the least subject to selection bias., (© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2017
- Full Text
- View/download PDF
183. Outbreak of Plague in a High Malaria Endemic Region - Nyimba District, Zambia, March-May 2015.
- Author
-
Sinyange N, Kumar R, Inambao A, Moonde L, Chama J, Banda M, Tembo E, Nsonga B, Mwaba J, Fwoloshi S, Musokotwane K, Chizema E, Kapin'a M, Hang'ombe BM, Baggett HC, and Hachaambwa L
- Subjects
- Adolescent, Child, Child, Preschool, Endemic Diseases, Female, Humans, Malaria epidemiology, Male, Plague prevention & control, Polymerase Chain Reaction, Yersinia pestis isolation & purification, Zambia epidemiology, Disease Outbreaks prevention & control, Plague epidemiology
- Abstract
Outbreaks of plague have been recognized in Zambia since 1917 (1). On April 10, 2015, Zambia's Ministry of Health was notified by the Eastern Provincial Medical Office of possible bubonic plague cases in Nyimba District. Eleven patients with acute fever and cervical lymphadenopathy had been evaluated at two rural health centers during March 28-April 9, 2015; three patients died. To confirm the outbreak and develop control measures, the Zambia Ministry of Health's Field Epidemiology Training Program (ZFETP) conducted epidemiologic and laboratory investigations in partnership with the University of Zambia's schools of Medicine and Veterinary Medicine and the provincial and district medical offices. Twenty-one patients with clinically compatible plague were identified, with symptom onset during March 26-May 5, 2015. The median age was 8 years, and all patients were from the same village. Blood specimens or lymph node aspirates from six (29%) patients tested positive for Yersinia pestis by polymerase chain reaction (PCR). There is an urgent need to improve early identification and treatment of plague cases. PCR is a potential complementary tool for identifying plague, especially in areas with limited microbiologic capacity. Twelve (57%) patients, including all six with PCR-positive plague and all three who died, also tested positive for malaria by rapid diagnostic test (RDT). Plague patients coinfected with malaria might be misdiagnosed as solely having malaria, and appropriate antibacterial treatment to combat plague might not be given, increasing risk for mortality. Because patients with malaria might be coinfected with other pathogens, broad spectrum antibiotic treatment to cover other pathogens is recommended for all children with severe malaria, until a bacterial infection is excluded.
- Published
- 2016
- Full Text
- View/download PDF
184. Streptococcus suis infection in hospitalized patients, Nakhon Phanom Province, Thailand.
- Author
-
Praphasiri P, Owusu JT, Thammathitiwat S, Ditsungnoen D, Boonmongkon P, Sangwichian O, Prasert K, Srihapanya S, Sornwong K, Kerdsin A, Dejsirilert S, Baggett HC, and Olsen SJ
- Subjects
- Adult, Aged, Humans, Incidence, Middle Aged, Molecular Typing, Population Surveillance, Serotyping, Streptococcal Infections diagnosis, Streptococcus suis genetics, Thailand epidemiology, Young Adult, Cross Infection, Streptococcal Infections epidemiology, Streptococcal Infections microbiology, Streptococcus suis classification
- Abstract
In Nakhon Phanom, Thailand, we identified 38 hospitalized patients with Streptococcus suis infection during 2006-2012. Deafness developed in 12 patients; none died. Thirty-five reported recent exposure to pigs/pork. Annual incidence was 0.1-2.2 cases/100,000 population (0.2-3.2 in persons ≥20 years of age). Clinicians should consider S. suis infection in areas where pig exposure is common.
- Published
- 2015
- Full Text
- View/download PDF
185. Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥ 50 years.
- Author
-
Dawood FS, Prapasiri P, Areerat P, Ruayajin A, Chittaganpitch M, Muangchana C, Baggett HC, and Olsen SJ
- Subjects
- Aged, Aged, 80 and over, Animals, Case-Control Studies, Female, Humans, Influenza Vaccines administration & dosage, Male, Middle Aged, Orthomyxoviridae genetics, Orthomyxoviridae isolation & purification, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Rural Population, Thailand, Treatment Outcome, Hospitalization statistics & numerical data, Influenza Vaccines immunology, Influenza, Human prevention & control
- Abstract
Background: Inactivated influenza vaccine (IIV) effectiveness has been evaluated among older adults in high-income countries, but data on IIV effectiveness in low- and middle-income countries remain sparse. We conducted a test-negative case-control analysis to estimate 2010 and 2011 trivalent IIV effectiveness against hospitalization with influenza-associated acute respiratory infection (ARI) among persons aged ≥ 50 years in rural Thailand., Methods: During 2010-2011, active surveillance for ARI hospitalization was conducted in two provinces; patients were tested for influenza viruses by real-time RT-PCR. Vaccination status was obtained from vaccine registries. Case and control patients were patients with nasopharyngeal swabs positive and negative for influenza viruses, respectively. Vaccine effectiveness (VE) was estimated for the 6 months after vaccination began. Logistic regression was used to evaluate the association between case status and vaccination while adjusting for age, province, medical conditions, and time., Results: During 2010-2011, there were 1545 patients with ARI, of whom 279 (18%) were influenza-positive case patients and 1266 (82%) were influenza-negative control patients. Of the 279 case patients, 247 (89%) had influenza A and 32 (11%) had influenza B. Fourteen of 279 (5%) case patients and 108 of 1266 (9%) control patients were vaccinated against influenza. The unadjusted IIV effectiveness against hospitalization with influenza-associated ARI was 43% (95% CI: 0-68%); adjusted VE was 47% (95% CI: 5-71%)., Conclusion: The 2010 and 2011 IIVs were moderately effective against hospitalization with influenza-associated ARI among Thais aged ≥ 50 years, but IIV coverage was low. Additional efforts are warranted in Thailand to improve IIV uptake in this target group., (© 2014 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.)
- Published
- 2014
- Full Text
- View/download PDF
186. Infective endocarditis in northeastern Thailand.
- Author
-
Watt G, Pachirat O, Baggett HC, Maloney SA, Lulitanond V, Raoult D, Bhengsri S, Thamthitiwat S, Paupairoj A, Kosoy M, Ud-Ai N, Sukwicha W, Whistler T, and Fournier PE
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Animals, Bacteria classification, Bacteria isolation & purification, Comorbidity, Endocarditis, Bacterial diagnosis, Endocarditis, Bacterial microbiology, Endocarditis, Bacterial transmission, Female, Humans, Male, Middle Aged, Risk Factors, Thailand epidemiology, Young Adult, Zoonoses microbiology, Zoonoses transmission, Endocarditis, Bacterial epidemiology
- Abstract
Despite rigorous diagnostic testing, the cause of infective endocarditis was identified for just 60 (45.5%) of 132 patients admitted to hospitals in Khon Kaen, Thailand, during January 2010-July 2012. Most pathogens identified were Viridans streptococci and zoonotic bacteria species, as found in other resource-limited countries where underlying rheumatic heart disease is common.
- Published
- 2014
- Full Text
- View/download PDF
187. Respiratory syncytial virus circulation in seven countries with Global Disease Detection Regional Centers.
- Author
-
Haynes AK, Manangan AP, Iwane MK, Sturm-Ramirez K, Homaira N, Brooks WA, Luby S, Rahman M, Klena JD, Zhang Y, Yu H, Zhan F, Dueger E, Mansour AM, Azazzy N, McCracken JP, Bryan JP, Lopez MR, Burton DC, Bigogo G, Breiman RF, Feikin DR, Njenga K, Montgomery J, Cohen AL, Moyes J, Pretorius M, Cohen C, Venter M, Chittaganpitch M, Thamthitiwat S, Sawatwong P, Baggett HC, Luber G, and Gerber SI
- Subjects
- Adult, Bangladesh epidemiology, Centers for Disease Control and Prevention, U.S., Child, Child, Preschool, China epidemiology, Climate, Disease Outbreaks, Egypt epidemiology, Female, Guatemala epidemiology, Humans, Infant, International Agencies, Kenya epidemiology, Male, Population Surveillance methods, Respiratory Syncytial Virus Infections virology, Respiratory Syncytial Virus, Human genetics, Respiratory Tract Infections virology, Seasons, South Africa epidemiology, Thailand epidemiology, United States, Weather, Developing Countries statistics & numerical data, Respiratory Syncytial Virus Infections epidemiology, Respiratory Syncytial Virus, Human isolation & purification, Respiratory Tract Infections epidemiology
- Abstract
Background: Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children globally, with the highest burden in low- and middle-income countries where the association between RSV activity and climate remains unclear., Methods: Monthly laboratory-confirmed RSV cases and associations with climate data were assessed for respiratory surveillance sites in tropical and subtropical areas (Bangladesh, China, Egypt, Guatemala, Kenya, South Africa, and Thailand) during 2004-2012. Average monthly minimum and maximum temperatures, relative humidity, and precipitation were calculated using daily local weather data from the US National Climatic Data Center., Results: RSV circulated with 1-2 epidemic periods each year in site areas. RSV seasonal timing and duration were generally consistent within country from year to year. Associations between RSV and weather varied across years and geographic locations. RSV usually peaked in climates with high annual precipitation (Bangladesh, Guatemala, and Thailand) during wet months, whereas RSV peaked during cooler months in moderately hot (China) and arid (Egypt) regions. In South Africa, RSV peaked in autumn, whereas no associations with seasonal weather trends were observed in Kenya., Conclusions: Further understanding of RSV seasonality in developing countries and various climate regions will be important to better understand the epidemiology of RSV and for timing the use of future RSV vaccines and immunoprophylaxis in low- and middle-income countries.
- Published
- 2013
- Full Text
- View/download PDF
188. Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis.
- Author
-
Lindsley MD, Mekha N, Baggett HC, Surinthong Y, Autthateinchai R, Sawatwong P, Harris JR, Park BJ, Chiller T, Balajee SA, and Poonwan N
- Subjects
- AIDS-Related Opportunistic Infections blood, AIDS-Related Opportunistic Infections urine, Antigens, Fungal blood, Antigens, Fungal urine, Cryptococcosis blood, Cryptococcosis urine, HIV Infections blood, HIV Infections urine, Humans, Sensitivity and Specificity, AIDS-Related Opportunistic Infections diagnosis, Antigens, Fungal analysis, Cryptococcosis diagnosis, Cryptococcosis virology, HIV Infections microbiology, Immunoassay methods
- Abstract
Background: Cryptococcosis is a common opportunistic infection of human immunodeficiency virus (HIV)-infected individuals mostly occurring in resource-limited countries. This study compares the performance of a recently developed lateral flow immunoassay (LFA) to blood culture and enzyme immunoassay (EIA) for the diagnosis of cryptococcosis., Methods: Archived sera from 704 HIV-infected patients hospitalized for acute respiratory illness in Thailand were tested for cryptococcal antigenemia using EIA. All EIA-positive and a subset of EIA-negative sera were tested by LFA, with results recorded after 5 and 15 minutes incubation. Urine from patients with LFA- and EIA-positive sera was tested by LFA. Antigen results from patients with positive cryptococcal blood cultures were compared., Results: Of 704 sera, 92 (13%) were positive by EIA; among the 91 EIA-positive sera tested by LFA, 82 (90%) and 87 (96%) were LFA positive when read after 5 and 15 minutes, respectively. Kappa agreement of EIA and LFA for sera was 0.923 after 5 minutes and 0.959 after 15 minutes, respectively. Two of 373 EIA-negative sera were LFA positive at both time points. Of 74 urine specimens from EIA-positive patients, 52 (70.3%) were LFA positive. EIA was positive in 16 of 17 sera from blood culture-positive patients (94% sensitivity), and all sera were positive by LFA (100% sensitivity)., Conclusions: A high level of agreement was shown between LFA and EIA testing of serum. The LFA is a rapid, easy-to-perform assay that does not require refrigeration, demonstrating its potential usefulness as a point-of-care assay for diagnosis of cryptococcosis in resource-limited countries.
- Published
- 2011
- Full Text
- View/download PDF
189. Bartonella seroprevalence in rural Thailand.
- Author
-
Bhengsri S, Baggett HC, Peruski LF, Morway C, Bai Y, Fisk TL, Sitdhirasdr A, Maloney SA, Dowell SF, and Kosoy M
- Subjects
- Adolescent, Adult, Age Distribution, Child, Female, Fluorescent Antibody Technique, Indirect, Humans, Immunoglobulin G blood, Male, Middle Aged, Prospective Studies, Rural Population, Seroepidemiologic Studies, Thailand epidemiology, Young Adult, Antibodies, Bacterial blood, Bartonella immunology, Bartonella Infections epidemiology
- Abstract
We estimated the prevalence of anti-Bartonella antibodies among febrile and non-febrile patients presenting to community hospitals in rural Thailand from February 2002 through March 2003. Single serum specimens were tested for IgG titers to four Bartonella species, B. henselae, B. quintana, B. elizabethae and B. vinsonii subsp vinsonii using an indirect immunofluorescent assay. A titer 21:256 was considered positive. Forty-two febrile patients (9.9%) and 19 non-febrile patients (19%) had positive serology titers to at least one Bartonella species. Age-standardized Bartonella seroprevalence differed significantly between febrile (10%) and non-febrile patients (18%, p=0.047), but did not differ by gender. Among all 521 patients, IgG titers 21:256 to B. henselae were found in 20 participants (3.8%), while 17 (3.3%) had seropositivity to B. quintana, 51 (9.8%) to B. elizabethae, and 19 (3.6%) to B. vinsonii subsp vinsonii. These results suggest exposure to Bartonella species is more common in rural Thailand than previously suspected.
- Published
- 2011
190. Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand.
- Author
-
Baggett HC, Peruski LF, Olsen SJ, Thamthitiwat S, Rhodes J, Dejsirilert S, Wongjindanon W, Dowell SF, Fischer JE, Areerat P, Sornkij D, Jorakate P, Kaewpan A, Prapasiri P, Naorat S, Sangsuk L, Eampokalap B, Moore MR, Carvalho G, Beall B, Ungchusak K, and Maloney SA
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Antigens, Bacterial blood, Blood microbiology, Child, Child, Preschool, Female, Humans, Incidence, Infant, Infant, Newborn, Male, Middle Aged, Rural Population, Thailand epidemiology, Young Adult, Bacteremia epidemiology, Hospitalization
- Abstract
Background: Population-based estimates of the incidence of invasive pneumococcal disease are unavailable for Thailand and other countries in Southeast Asia. We estimated the incidence of pneumococcal bacteremia cases requiring hospitalization in rural Thailand., Methods: Blood cultures were performed on samples from hospitalized patients in 2 rural provinces where active, population-based surveillance of community-acquired pneumonia is conducted. Blood cultures were performed at clinician discretion and were encouraged for all patients with suspected pneumonia and all children aged <5 years with suspected sepsis. Pneumococcal antigen testing was performed on positive blood culture specimens that failed to grow organisms on subculture., Results: From May 2005 through June 2007, 23,853 blood culture specimens were collected overall, and 7319 were collected from children aged <5 years, which represented 66% and 47% of target patients, respectively. A total of 72 culture-confirmed pneumococcal bacteremia cases requiring hospitalization were identified. An additional 44 patients had media from positive blood cultures that yielded no growth on subculture but that had positive results of pneumococcal antigen testing. Of the 116 confirmed cases of bacteremia, 27 (23%) occurred in children aged <5 years; of these, 9 (33%) were confirmed by antigen testing only. The incidence of pneumococcal bacteremia cases requiring hospitalization among children aged <5 years had a range of 10.6-28.9 cases per 100,000 persons (incidence range if cases detected by antigen are excluded, 7.5-14.0 cases per 100,000 persons)., Conclusions: Invasive pneumococcal disease is more common than was previously suspected in Thailand, even on the basis of estimates limited to hospitalized cases of bacteremia. These estimates, which are close to estimates of the incidence of hospitalized cases of pneumococcal bacteremia in the United States before introduction of pneumococcal conjugate vaccine, provide important data to guide public health care policy and to inform discussions about vaccine introduction in Thailand and the rest of Southeast Asia.
- Published
- 2009
- Full Text
- View/download PDF
191. Epidemiology of radiographically-confirmed and bacteremic pneumonia in rural Thailand.
- Author
-
Prapasiri P, Jareinpituk S, Keawpan A, Chuxnum T, Baggett HC, Thamathitiwat S, and Olsen SJ
- Subjects
- Adolescent, Adult, Aged, Bacteremia epidemiology, Bacteremia microbiology, Bacteremia mortality, Child, Child, Preschool, Comorbidity, Female, HIV Infections epidemiology, Humans, Incidence, Male, Middle Aged, Pneumonia, Bacterial diagnostic imaging, Pneumonia, Bacterial microbiology, Pneumonia, Bacterial mortality, Population Surveillance, Radiography, Rural Health, Thailand epidemiology, Young Adult, Pneumonia, Bacterial epidemiology
- Abstract
Pneumonia remains a leading public health concern in Thailand. Using population-based surveillance during January 2004-December 2006, we describe incidence, mortality, and bacterial etiologies of chest radiograph-confirmed pneumonia requiring hospitalization in one rural Thai province. Of 19,316 patients who met the case definition for clinical pneumonia, 9,596 (50%) had a chest radiograph, and 4,993 (52%) of those had radiographically-confirmed pneumonia. The incidence of radiographically-confirmed pneumonia ranged from 199 to 256 per 100,000 persons per year; 151 (3.0%) patients died. The annual average pneumonia mortality rate was 6.9 per 100,000 persons (range 6.2 to 7.8 per 100,000) and was highest in persons aged < 1 year (64/100,000) and > or = 65 years (44/100,000). Of 4,993 patients with radiographically-confirmed pneumonia, 1,916 (38%) had blood cultures, and 187 (10%) of those had pathogens isolated. Pathogens causing bacteremic pneumonia included B. pseudomallei (15% to 24% of bacterial pathogens), E. coli (9.2% to 25%), S. pneumoniae (7.9% to 17%), K. pneumoniae (2.2% to 6.4%), and S. aureus (4.3 to 5.3%). Bacteremia was significantly associated with pneumonia mortality after controlling for age, sex, HIV status and measures of disease severity in a logistic regression model (OR=5.2; 95% confidence interval= 2.2-12). Pneumonia remains an important cause of morbidity and mortality in Thailand, as in other countries in Southeast Asia. These findings can inform pneumonia clinical management and treatment decisions and guide public health programming, including the development of effective prevention strategies.
- Published
- 2008
192. Two nosocomial pertussis outbreaks and their associated costs - King County, Washington, 2004.
- Author
-
Baggett HC, Duchin JS, Shelton W, Zerr DM, Heath J, Ortega-Sanchez IR, and Tiwari T
- Subjects
- Adult, Bordetella pertussis isolation & purification, Contact Tracing, Cross Infection epidemiology, Cross Infection microbiology, Cross Infection prevention & control, Disease Outbreaks prevention & control, Female, Health Personnel, Hospitals, General economics, Hospitals, Pediatric economics, Humans, Infection Control methods, Interviews as Topic, Organizational Case Studies, Polymerase Chain Reaction, Pregnancy, Washington epidemiology, Whooping Cough prevention & control, Cross Infection economics, Disease Outbreaks economics, Hospital Costs, Infection Control economics, Whooping Cough economics, Whooping Cough epidemiology
- Abstract
Objective: Pertussis outbreaks in healthcare settings result in resource-intensive control activities, but studies have rarely evaluated the associated costs. We describe and estimate costs associated with 2 nosocomial pertussis outbreaks in King County, Washington, during the period from July 25 to September 15, 2004. One outbreak occurred at a 500-bed tertiary care hospital (hospital A), and the other occurred at a 250-bed pediatric hospital (hospital B)., Methods: We estimated the costs of each outbreak from the hospitals' perspective through standardized interviews with hospital staff and review of contact tracing logs. Direct costs included personnel time and laboratory and medication costs, whereas indirect costs were those resulting from hospital staff furloughs., Results: Hospital A incurred direct costs of $195,342 and indirect costs of $68,015; hospital B incurred direct costs of $71,130 and indirect costs of $50,000. Cost differences resulted primarily from higher personnel costs at hospital A ($134,536), compared with hospital B ($21,645). Total cost per pertussis case was $43,893 for hospital A (6 cases) and $30,282 for hospital B (4 cases). Total cost per person exposed to a pertussis patient were $357 for hospital A (738 exposures) and $164 for hospital B (737 exposures)., Conclusions: Nosocomial pertussis outbreaks result in substantial costs to hospitals, even when the number of pertussis cases is low. The cost-effectiveness of strategies to prevent nosocomial pertussis outbreaks, including vaccination of healthcare workers, should be evaluated.
- Published
- 2007
- Full Text
- View/download PDF
193. Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska.
- Author
-
Baggett HC, Hennessy TW, Bulkow L, Romero-Steiner S, Hurlburt D, Holder P, Parkinson AJ, Singleton RJ, Levine O, Carlone GM, and Butler JC
- Subjects
- Adolescent, Adult, Alaska epidemiology, Antibodies, Bacterial blood, Antibody Affinity physiology, Bacterial Vaccines administration & dosage, Carrier State ethnology, Carrier State prevention & control, Case-Control Studies, Child, Child, Preschool, Enzyme-Linked Immunosorbent Assay methods, Female, Follow-Up Studies, Haemophilus Infections prevention & control, Humans, Male, Risk Factors, Rural Population, Time Factors, Vaccines, Conjugate immunology, Carrier State epidemiology, Haemophilus Infections epidemiology, Haemophilus Vaccines immunology, Haemophilus influenzae type b chemistry
- Abstract
Continued Haemophilus influenzae type b (Hib) carriage in rural Alaska contributes to the ongoing risk of invasive disease. Community-wide Hib carriage surveys were conducted in three villages in southwestern Alaska. Sixteen carriers and 32 age- and village-matched controls were enrolled and were vaccinated with Hib oligosaccharide-CRM(197) conjugate vaccine. Serum immunoglobulin G (IgG) concentration, antibody avidity, and serum bactericidal activity (SBA) were measured prior to Hib vaccination and 2 and 12 months after vaccination. We identified no demographic or behavioral factors associated with Hib colonization. Prior to vaccination, Hib carriers had a higher IgG geometric mean concentration than controls did (8.2 versus 1.6 microg/ml; P < 0.001) and a higher SBA geometric mean titer (7,132 versus 1,235; P = 0.006). Both groups responded to vaccination with increased IgG and SBA. These data illustrate the role of Hib colonization as an immunizing event and show that Hib carriers in communities with ongoing transmission have no evidence of reduced immune responsiveness that may have put them at risk for colonization.
- Published
- 2006
- Full Text
- View/download PDF
194. A controlled, household-randomized, open-label trial of the effect that treatment of Helicobacter pylori infection has on iron deficiency in children in rural Alaska.
- Author
-
Gessner BD, Baggett HC, Muth PT, Dunaway E, Gold BD, Feng Z, and Parkinson AJ
- Subjects
- Alaska, Anemia, Iron-Deficiency diagnosis, Anemia, Iron-Deficiency epidemiology, Anemia, Iron-Deficiency microbiology, Anti-Bacterial Agents adverse effects, Child, Drug Therapy, Combination, Family Characteristics, Female, Helicobacter Infections complications, Helicobacter pylori drug effects, Humans, Iron metabolism, Iron Metabolism Disorders, Male, Rural Population, Treatment Outcome, Anemia, Iron-Deficiency complications, Anti-Bacterial Agents therapeutic use, Helicobacter Infections drug therapy
- Abstract
Background: Helicobacter pylori infection and iron deficiency are prevalent in disadvantaged populations worldwide. Previous small or uncontrolled studies have reported that successful treatment of H. pylori infection may resolve iron deficiency or anemia., Methods: We screened 68% of children 7-11 years old living in 10 western Alaska villages. The 219 children with iron deficiency (serum ferritin level, <22.5 pmol/L [<10 microg/L]) and H. pylori infection (diagnosed on the basis of (13)C-labeled urea breath tests) were enrolled in a household-randomized, unblinded trial. All children received iron supplementation for 6 weeks; children in the intervention group also received a 2-week course of treatment for H. pylori infection plus another 2-week course of treatment if the infection had not resolved at 2 months after treatment initiation., Results: At 2 months after treatment initiation, 32% of children in the intervention group and 39% of children in the control group had iron deficiency. At 14 months after treatment initiation, 65% of children in the intervention group and 72% of children in the control group had iron deficiency (adjusted relative risk [ARR], 0.90 [95% confidence interval [CI], 0.74-1.1]); in addition, 22% of children in the intervention group and 14% of children in the control group had anemia (ARR, 1.6 [95% CI, 0.86-2.9]). Results were similar when children were compared by H. pylori infection status., Conclusions: In a high-prevalence population, treatment and resolution of H. pylori infection did not improve isolated iron deficiency or mild anemia up to 14 months after treatment initiation.
- Published
- 2006
- Full Text
- View/download PDF
195. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska.
- Author
-
Baggett HC, Hennessy TW, Rudolph K, Bruden D, Reasonover A, Parkinson A, Sparks R, Donlan RM, Martinez P, Mongkolrattanothai K, and Butler JC
- Subjects
- Adolescent, Adult, Alaska epidemiology, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Bacterial Toxins, Case-Control Studies, Child, Child, Preschool, Community-Acquired Infections microbiology, Exotoxins metabolism, Female, Furunculosis microbiology, Humans, Infant, Infant, Newborn, Leukocidins metabolism, Male, Methicillin pharmacology, Methicillin therapeutic use, Population Surveillance, Risk Factors, Rural Population, Staphylococcus aureus genetics, Staphylococcus aureus metabolism, Community-Acquired Infections epidemiology, Disease Outbreaks, Furunculosis epidemiology, Leukocidins genetics, Methicillin Resistance, Staphylococcus aureus drug effects
- Abstract
Background: Community-onset methicillin-resistant Staphylococcus aureus (CO-MRSA) reports are increasing, and infections often involve soft tissue. During a CO-MRSA skin infection outbreak in Alaska, we assessed risk factors for disease and whether a virulence factor, Panton-Valentine leukocidin (PVL), could account for the high rates of MRSA skin infection in this region., Methods: We conducted S. aureus surveillance in the outbreak region and a case-control study in 1 community, comparing 34 case patients with MRSA skin infection with 94 control subjects. An assessment of traditional saunas was performed. S. aureus isolates from regional surveillance were screened for PVL genes by use of polymerase chain reaction, and isolate relatedness was determined by use of pulsed-field gel electrophoresis (PFGE)., Results: Case patients received more antibiotic courses during the 12 months before the outbreak than did control subjects (median, 4 vs. 2 courses; P=.01) and were more likely to use MRSA-colonized saunas than were control subjects (44% vs. 13%; age-adjusted odds ratio, 4.6; 95% confidence interval, 1.7-12). The PVL genes were present in 110 (97%) of 113 MRSA isolates, compared with 0 of 81 methicillin-susceptible S. aureus isolates (P<.001). The majority of MRSA isolates were closely related by PFGE., Conclusion: Selective antibiotic pressure for drug-resistant strains carrying PVL may have led to the emergence and spread of CO-MRSA in rural Alaska.
- Published
- 2004
- Full Text
- View/download PDF
196. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska.
- Author
-
Baggett HC, Hennessy TW, Leman R, Hamlin C, Bruden D, Reasonover A, Martinez P, and Butler JC
- Subjects
- Adolescent, Adult, Aged, Alaska epidemiology, Anti-Bacterial Agents therapeutic use, Child, Child, Preschool, Cohort Studies, Community-Acquired Infections epidemiology, Female, Humans, Infant, Male, Middle Aged, Retrospective Studies, Rural Population, Staphylococcal Skin Infections drug therapy, Staphylococcal Skin Infections microbiology, Disease Outbreaks, Methicillin Resistance, Staphylococcal Skin Infections epidemiology, Staphylococcus aureus isolation & purification
- Abstract
Objective: We investigated a large outbreak of community-onset methicillin-resistant Staphylococcus aureus (MRSA) infections in southwestern Alaska to determine the extent of these infections and whether MRSA isolates were likely community acquired., Design: Retrospective cohort study., Setting: Rural southwestern Alaska., Patients: All patients with a history of culture-confirmed S. aureus infection from March 1, 1999, through August 10, 2000., Results: More than 80% of culture-confirmed S. aureus infections were methicillin resistant, and 84% of MRSA infections involved skin or soft tissue; invasive disease was rare. Most (77%) of the patients with MRSA skin infections had community-acquired MRSA (no hospitalization, surgery, dialysis, indwelling line or catheter, or admission to a long-term-care facility in the 12 months before infection). Patients with MRSA skin infections were more likely to have received a prescription for an antimicrobial agent in the 180 days before infection than were patients with methicillin-susceptible S. aureus skin infections., Conclusions: Our findings indicate that the epidemiology of MRSA in rural southwestern Alaska has changed and suggest that the emergence of community-onset MRSA in this region was not related to spread of a hospital organism. Treatment guidelines were developed recommending that beta-lactam antimicrobial agents not be used as a first-line therapy for suspected S. aureus infections.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.